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Red cell fragmentation (RCF) in single needle dialysis (SND). R.
Hombrouckx, A.M. Bogaert, F. Leroy, J. Y. De Vos, L. Larno, G. Van
Overmeeren, G. De Rekeneire, C. Ba/caen, Dialysis Unit, Kliniek
Hogerlucht, 9600 Ronse, Belgium. During 10,000 SND sessions the
occurrence of RCF was systematically screened. Causes of intravascu-
lar hemolysis (HL) other than the mechanical destruction of red blood
cells (RBC) were excluded. We selected the rise in serum lactic
dehydrogenase level (LDH) during the SND as a suitable HL index
(HLI). We found some degree of RCF in most patients during every
dialysis, mostly subclinical, but in some patients presenting with
unexpected symptoms such as retrosternal pain, abdominal pain, long-
lasting hypotension, dyspnea, flushing, and esophageal spasms. Other
symptoms could be considered as typical for intravascular HL. The
HLI per patient is more or less a constant factor. Surprising was the fact
that patients with a constant HLI on peripheral needle-fistula SND
showed no signs of RCF when dialyzed on a central catheter with the
same SND device. This enabled us to localize the site of RCF: namely
the tip of the peripheral needle (too high shear stress). We tried to
influence the degree of RCF by adding to the dialysate: Vitamin C,
glucose, ATP, alone or in combination, but without positive result.
Anemia and liver iron overload (biopsy proven and of endogenous
origin, and not corresponding with the HLA typing of idiopathic
haemochromatosis) are the long term results of RCF, even in patients
without transfusions or iron therapy.
Fibrin sheet covering subelavian or femoral dialysis catheters. R.
Hombrouckx, F. D'Halluin, A.M. Bogaert, F. Leroy, L. Larno, J. Y. De
Vos, Dialysis Unit, Kliniek Hogerlucht, 9600 Ronse, Belgium. It often
happens that a single lumen dialysis catheter (SLDC) in combination
with a single needle dialysis system, allows a good venous return, but
not a good arterial supply, suggesting a sort of valve mechanism in, or
around the SLDC-tip. Replacement of the SLDC mostly fails to show
kinking, or thrombus in the SLDC, while the new SLDC (in exactly the
same place), provides a good arterial supply. The suspicion of the
existence of a sheet around the SLDC-tip, provoking a valve mecha-
nism, is supported by the observation that several times during the
replacement maneuvers of a SLDC, a sheet surrounding the surface of
the SLDC is removed together with the SLDC. This sheet is grey, about
1 mm thick and about 30 mm long and consists of fibrin and thrombo-
cytes. Bacteriological examinations are always negative. The existence
of the sheet in vivo is demonstrated by a digital angiography during the
removal of the SLDC; only exceptionally the sheet is removed together
with the SLDC, in all other instances it is stripped off and remains in the
subcutaneous tunnel or in the vascular bed, without causing much
clinical discomfort in most cases. Occasionally, an episode of cough,
dyspnea, hypotension, retrosternal oppression or hemoptyos, after the
removing of a SLDC, suggests pulmonary embolization or lung infarc-
tion.
Bidirectional (BD) blood pump with a bidirectional blood passage
through the artificial kidney (AK). R. Hombrouckx, R. Beelen, A.M.
Bogaert, F. Leroy, Dialysis Unit, Kliniek Hogerlucht, 9600 Ronse,
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Belgium. A new type of single needle dialysis system was developed,
inspired by the highly efficient pigeon's respiratory system: a double
passage through the exchange organ was envisaged. We therefore
tested a BD-pump that first lifts the blood through the unique needle,
the unique bloodline and the AK, fills up and expansion chamber (EC)
placed above the AK (= first passage), and then switches direction at a
preselected maximum pressure in the EC and empties this EC through
the AK again (= second passage). The pump (and ultrafiltration) is
directed by a minimum and maximum manometer setting. The extrac-
tion profile of the blood (compared with the classical single pass system)
shows the same extraction rate for small molecules, but a higher
extraction rate for phosphate and large molecules such as Amikacin,
digoxin and inulin (due to the BD-passage: especially of interest for
otherwise poorly dialyzed molecules). The main disadvantage of the
system is some amount of recirculation of non-filtered blood, namely
the content of bloodline, pump segment and lower part of the AK. For
this reason the bloodline, pump and AK are kept as small as possible.
However, this recirculation or "ineffective blood flow" is overcompen-
sated by the "effective blood flow." We consider it as a tool for daily
ultrashort (1.5 hr) home hemodialysis. The system is very simple (can
be applied by a patient alone without partner), is very cheap, has a low
bloodpriming and permits perfect ultrafiltration control.
Treatment of resistant andlor malignant ascites by a hemodialysis
technique. R. Hombrouckx, AM. Bogaert, F. Leroy, J.Y. De Vos, L.
Larno, C. De Vlieger, C. Balcaen, G. De Rekeneire, Dialysis Unit,
Kliniek Hogerlucht, 9600 Ronse, Belgium.Therapy resistant ascites
(liver cirrhosis) was treated repetitively by ascites drainage through a
peritoneal dialysis catheter (Troucath McGaw: cat. nr.4900). The
ascitic fluid, collected during 2 hours of drainage, was simultaneously
filtered through a polymethylmethacrylate (PMMA) membrane of 1.56
m2 surface (Filtryzer B 1-1.5 Toray). The ultrafiltrate was drained, and
the concentrated ascitic fluid, consisting mainly of proteins, was
reinfused through a peripheral vein. The ascitic proteins were concen-
trated up to 3 times during the ultrafiltration process. In this way we
succeeded in eliminating up to 7 liters of ascites in a 2 hour session,
without symptoms of hypovolemia. The sessions were repeated accord-
ing to the clinical needs (once every week to once every 4 weeks) and
were very well tolerated. This treatment is a worthly alternative for
repeated low-volume ascites drainage and for a Le Veen shunt. We also
reinfused concentrated malignant ascitic fluid, without clinical symp-
toms during the reinfusion period, without symptoms of diffuse con-
sumption coagulopathy, and without change in the clinical progression
of the malignant process. In one case a decrease in tumor growth was
temporarily noted.
Cyclosporin-induced hypertension (CIH) in the conscious sheep: Dose
response and renal responses to atrial natriuretic peptide (ANP). J.A.
Whitworth, J.J. Tresham, J.G. McDougall, NA. Yates, BA. Scoggins,
W.M. Bennet, Howard Florey Institute of Experimental Physiology and
Medicine, University of Melbourne; Deparment of Nephrology, Royal
Melbourne Hospital, Victoria 3050, Australia. CIH is frequent clini-
cally but only inconsistently occurs in anesthetized animal models. We
have reported increased mean arterial pressure (MAP) in conscious
sheep given cyclosporin A (CSA), 12 mg/kg iv. for 5 days without
reduced glomerular filtration rate (GFR), effective renal plasma flow
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(ERPF) or increased plasma renin activity (Clin Exp Physiol Pharm
14:573, 1987). We have examined dose-response relationships for CIH
over the range 3 to 24 mg/kg i.v. CSA induced increases in MAP were
as follows: 3 mg/kg, N = 2, = 2.5 0.5 mm Hg; 6 mg/kg, N = 4,
= 10.3 2.3; 12 mg/kg, N = 7, z = 9.0 0.9; 24 mg/kg, N = 3, =
7.7 1.5 mm Hg, suggesting that 6 mg/kg produces a maximal effect. In
separate studies we examined the effect of CSA 12 mg/kg i.v. on renal
responsiveness to ANP. The natriuretic effect of the hormone was
attenuated (P < 0.05) to a small degree, while responses of renal
hemodynamics and lithium clearance to ANF were not affected by
CSA. CSA has potent hypertensive effects in conscious sheep at doses
releavant to those used in clinical practice.
cDNA probes for constituents of the lamina densa of the glomerular
basement membrane. J.A. Savige, L. Mavrova, D. Temelcos, B.A.
Evans, R.I. Richards, P. Kincaid-Smith, Department of Nephrology,
Royal Melbourne Hospital, and Genetic Engineering Laboratory, How-
ardFlorey Institute, University of Melbourne, Victoria, Australia. Thin
basement membrane disease is characterised histologically by attenua-
tion of the lamina densa of the glomerular basement membrane, the
principal components of which are type IV collagen and laminin. The
genetic defect responsible is probably analogous to that of osteogenesis
imperfecta, where the disease is associated with restriction fragment
length polymorphisms of the type I collagen gene on Southern blot
analysis of genomic DNA. We describe here: cloning of cDNA for the
al and a2 chains of type IV collagen, and for the 2 chain of laminin;
and the use of these cDNA to analyse the defect in a family with thin
basement membrane disease. A cDNA library of 500,000 independent
clones was constructed in lambda gtlo from mRNA extracted from a
human fibrolameilar tumour of the liver, Using oligonucleotide probes,
2 clones for the al chain and 1 each for the a2 chain of type IV collagen
and the 2 chain of laminin were isolated. A restriction fragment length
polymorphism was demonstrated with Hindill-cut genomic DNA, but
there was no segregation of a specific allele with thin basement
membrane disease in the single pedigree investigated. We conclude that
it is unlikely that thin basement membrane disease is an abnormality of
the al chain of type IV collagen in this family. We are currently
searching for polymorphisms with the a2 and laminin probes.
Immunocytology of the urine sediment in glomerulonephritis. M.
Segasothy, K.F. Fairley, D.F. Birch, P. Kincaid-Smith, Department of
Nephrology, Royal Melbourne Hospital, Melbourne, Victoria 3050,
Australia. The morphology and numbers of urinary erythrocytes is a
valuable guide to diagnosis and prognosis in giomeruionephritis. Nu-
cleated cells in urine of patients with glomeruionephritis have not been
studied. We used the immunoperoxidase technique using monocionai
antibodies (Am J Clin Pathol 90:51—56, 1988) to identify and quantify
nucleated cells in urine of patients with crescentic giomerulonephritis
(CN) (N = 20) and noncrescentic glomeruionephritis (NCN) (N = 12).
The diagnosis was confirmed in all cases by renal biopsy. Mann-
Whitney rank sum tests and Chi squared tests were performed to
determine significant differences in the cell types between the 2 groups.
CN was distinguishable from NCN by total cell numbers exceeding
30,000/mi (P < 0.001) and counts of granulocytes exceeding 10,000/mI(P < 0.05), monocytes exceeding 3000/mi (P < 0.001), T4 lymphocytes
exceeding 1500/mi (P < 0.001),T8 lymphocytes exceeding 1500/mi (P <
0.001), glomerular epithelial cells exceeding 3000/mi (P < 0.001),
proximal tubular cells exceeding 8000/mi (P < 0.001), loop of Henle
cells exceeding 1500/mi (P < 0.001), and urothelial cells exceeding
1500/mi (P < 0.01). High numbers of glomeruiar epitheiial cells and
monocytes in CN suggest that both may be involved in crescent
formation. Presence of large numbers of inflammatory and tubular cells
in CN suggest that associated tubuiointerstitial damage is an important
contributory factor towards renal failure. It is concluded that the
identification of nucleated cells in urine is helpful in the diagnosis of
glomeruionephntis.
Immunocytology of the urine sediment in 'sterile pyruria'. M. Segas-
othy, K.F. Fairley, D.F. Birch, P. Kincaid-Smith, Department of
Nephrology, Royal Melbourne Hospital, Melbourne, Victoria 3050,
Australia. Pyuria is a common feature of analgesic nephropathy (AN)
and polycystic kidney disease (PCKD). To identify nucleated non-
squamous cells in the urine, culture negative midstream urine of
patients with AN (N = 9), PCKD (N = 13) and medullary sponge
kidney disease (MSKD) (N = 3) were examined with an immunoper-
oxidase technique using monocionai antibodies (Am J Gun Pathol
90:51—56, 1988). Eosinophils were identified with Leishman stain. Cell
viability was determined by trypan blue exclusion. Patients with
culture-proven infection were excluded from the study. There were no
significant differences in the total cell count, numbers of the different
cell types and cell viability between the 3 conditions as determined by
Mann-Whitney rank sum tests. Granulocytes were the predominant
cells in each patient category (84 to 86%) followed by tubular (proximal
and distal tubular/collecting duct) cells (8 to 12%). Monocytes (ito 3%)
and eosinophiis (2—3%) were present in very low numbers while
lymphocytes, glomerular epithelial cells and loop of Henie cells were
absent in all 3 conditions. There was no correlation between the
numbers and types of cells in urine and serum creatinine and creatinine
clearance for the 3 conditions as assessed by analysis of variance,
suggesting that these parameters are not useful as markers for deter-
mining progression towards renal failure. In conclusion, most of the
nucleated nonsquamous cells seen in urine of uninfected patients with
AN, PCKD and MSKD are granulocytes.
Use of the 3'HVR DNA probe in a Mediterranean population with adult
poiycystic kidney disease. J.A. Savige, M.C. Gill, P. Kincaid-Smith,
Department of Nephrology, Royal Melbourne Hospital, Victoria 3050,
Australia. The gene for adult polycystic kidney disease has recently
been localized to the long arm of chromosome 16 in a Northern
European population. The associated DNA sequence, 3'HVR detects
DNA polymorphisms that segregate with the disease in 95% of individ-
uals from affected families. However, a second genetic locus for this
condition has been described in an Italian family, and we have inves-
tigated the usefulness of the 3'HVR probe in a Mediterranean popula-
tion. Of 19 families of Mediterranean origin with adult poiycystic kidney
disease, 6 were studied in detail, 4 refused investigation and 9 were too
small to be informative. Of the 6 families studied, 5 were of Greek
background and one Italian. Consenting family members were bled, the
DNA extracted from peripheral blood leucocytes and cut with PvuII.
DNA was eiectrophoresed in 0.8% agarose gels and blotted onto
nitrocellulose. Filters were hybridized overnight with the 32P-iabelled 4
kb 3'HVR probe (provided by Stephen Reeders) in 50% formamide and
then washed in 0.1 x SSC at 65°C and exposed to X-AR film. We were
able to correlate the presence of a distinctively-sized band on the
autoradiographs with ultrasound evidence of multiple cysts in the
kidneys in all 6 families. While linkage must be demonstrated in each
family before predictive probes can be used reliably, the 3'HVR
appears to be useful in making the diagnosis of adult poiycystic kidney
disease in the majority of a Caucasian population.
Introducing microcomputer applications to a renal service. M.S.
Knapp, P. Baxter, Renal Unit, Austin Hospital, Melbourne, Victoria
3084, Australia. Clinical Units are slow to use computers despite their
potential to contribute to many routine and research activities. Aspira-
tions by Renal Units to computerize are constrained by hospital
policies, by inadequate funding and because of the non-availability of
expertise. Problems that are soluble by the use of low-cost computing
are common. A planned strategy on how to introduce computing with
decisions on priorities was considered to be more sensible than random
development. In April 1987 an analysis of the computing needs of the
Renal Unit identified groups of computer applications, some mainframe
and some micro-based: (I) implemented and satisfactory—word-proc-
essing, computerized laboratory results; (2) less satisfactory, and with
the potential for improvement—e.g. graphic presentations of data,
computer generated discharge summaries, records of prescribed medi-
cations; (3) those that could be introduced quickly using low cost
microcomputers and "off the shelf' programmes modified for local
needs (e.g. real time statistics monitoring, bibliography records, nutri-
tion analysis, computer-assisted learning, slide and overhead transpar-
ency production, tuition and training packages); (4) those not feasible
without prolonged effort and/expenditure; (5) those offering little ad-
vantage over existing practice. Failure to utilize the facilities available
was mostly due to the lack of time to train staff in using the techniques,
and of a training strategy. Experience with members of staff allocated a
role as trainers including a full-time but temporary liaison/training
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officer and the use of computer-enhanced training methods will be
reported.
Pharmacokinetics of qutnapril and its active metabolite in renal failure.
R.A. Robson, E.J. Begg, K.L. Lynn, R,R. Bailey, Departments of
Nephrology and Clinical Pharmacology, Christchurch Hospital,
Christchurch, Australia. This study evaluated the pharmacokinetics of
the new ACE inhibitor, quinapril, and its active metabolite, in hyper-
tensive patients with normal renal function and with varying degrees of
renal insufficiency. Twenty subjects (15 M, 5 F) of mean age 39 (range
20 to 65) years and mean weight 75 (range 50 to lOS) kg were studied.
Subjects were placed into four groups according to their estimated
creatinine clearance (Car ml/minll.73 m2), Subjects received 20 mg
quinapril immediately after breakfast for 7 days. On day 7, venous
blood samples were obtained over the next 72 hr, and all urine over 24
hr. Quinapril and its active metabolite were assayed using a specific gas
chromatographic method with electron capture. Standard methods
were used to calculate the pharmacokinetic parameters, plasma clear-
ance (Ce) and half-life (t112) for quinapril and its active metabolite.
Quinapril (mean SD) Metabolite (mean sn)
Cr C,
mI/mm C, mI/mm t112 hours mI/mm t112 hours
>90 2095 493 0.8 0.2 191 51 2.3 0.7
60—90 2067 906 0.9 0.5 108 27 2.9 0.8
30—60 1317 268 0.8 0.1 53 27 7.3 3.6
<30 1255 481 0.9 0.3 21 11 11.5 3.5
No significant changes occurred in the quinapril pharmacokinetic
parameters with renal insufficiency. There were small changes in the
rate of production and a decreased rate of clearance of the metabolite in
patients with renal insufficiency. Patients with Cr <40 mI/mm should
receive the lowest recommended starting dose and be gradually titrated
to an efficacious dose.
Human papillomavirus infection in female renal transplant recipients.
B.D. Cleland, G.E. Kelly, R.J. Caterson, D.A. Waugh, J.D. Lundie,
J.F. Mahony, Department of Renal Medicine, Royal North Shore
Hospital, St. Leonards & Department of Surgery, University of Syd-
ney, NSW. 2006, Australia. Human papillomavirus (HPV) infection of
the female genital tract is rising in incidence in the general population.
The association between HPV infection and cervical cancer is well
established. Female renal transplant patients (RTx) are at increased risk
from cervical cancer. Hence, we have determined the incidence of
genital HPV infection in 48 RTx and in a control group of 55 women.
HPV infection was ascertained using the DNA hybridization technique
for HPV types 6/Il and 16/18 on Pap smears. HPV types 16/18 are
strongly implicated in the development of cervical cancer. The patients
also underwent routine Pap smear examinations and answered a ques-
tionnaire on sexual activity, cigarette smoking and history of prior
genital wart infection or genital cancer. The incidence of HPV 6/Il
infection was 10.4% in the RTx and 0% in the controls (P < 0.02). HI'V
16/18 was found in 14.6% of RTx and 9.1% of controls (P> 0.1). The
combination of infection with both 6/11 and 16/18 was found in 6.3% of
RTx and 3.6% of controls (P > 0.1). The total incidence of HPV
infection in the RTx group was 31.3% and in the control group 12.7% (P
< 0.05). On Pap smear cytology neither group had patients with
dysplastic changes and only one transplant recipient had cytological
evidence of HPV infection. Those RTx who were HPV positive
underwent colposcopy and these results will be presented. Hence, the
study demonstrated a significantly higher incidence of HPV 6/li infec-
tion in RTx; although the incidence of HPV 16/18 infection was higher
in the RTx this was not statistically significant.
End-stage renal failure (ESRD) in children: 16 years experience at one
centre. E.M. Hodson, J.F. Knight, A.G.R. Shell, L.P. Roy, Depart-
ment of Nephrology, Royal Alexandra Hospital for Children and
Department of Surgery, Royald Prince Alfred Hospital, Camperdown,
NSW 2050, Australia. Between March 1973 and September 1988, 65
children (37 boys, 19 girls) aged 1.0 to 14.9 years entered the combined
treatment program for ESRD at Royal Alexandra Hospital for Children
and Royal Prince Alfred Hospital. Currently 51(78%) patients are alive;
I patient has been lost to follow-up. Thirteen children died including 3
with functioning grafts; causes of death were hyperkalemia (3), acci-
dental drowning (1), sepsis (2), cardiomyopathy (I), cerebral hemor-
rhage (3), and uremia following elective withdrawal of therapy (3).
Actuarial 5 and 10 year patient survival rates were 79% and 75%.
Fifty-three of these children have received 61 transplants, 39 (36 first, 3
second) from living donors (LD) and 22 (17 first, 5 second) from
cadaveric donors. At present 39 transplants are functioning. Eighteen
transplants failed from rejection (12), disease recurrence (5) or primary
non-function (I). Actuarial 5 and 10 year graft survival rates for all first
grafts were 66% and 53% and for LD first grafts were 85% and 68%.
Thirty-two (82%) of 39 transplant patients and 7 (58%) of 12 dialysis
patients are attending school or working full time. Mean height standard
deviation score (SDS) was —2.01 1.41 at program entry. Height fell
by 0.4 0.24 SDS/year in dialyzed children. Transplanted children on
prednisone with creatinine levels below 300 mol/liter had no increase
in growth rate (change in SDS/year —0.02 0.35) while children on
cyclosporin A alone showed catch up growth (change in SDS/year
+0.36 0.25). Dialysis and transplantation are acceptable therapies for
children with ESRD. Successful transplantation provides the best
opportunity for satisfactory growth and rehabilitation.
A mechanism of plasma volume reduction in pregnancy-induced hyper-
tension. M.A. Brown, S.A. Lowe, V. Zammit, Departments of Renal
Medicine and Obstetrics, The St. George Hospital, Kogarah, N.S. W.
2217, Australia. A reduction in maternal plasma volume occurs in
women with pregnancy-induced hypertension (PIH) but the mecha-
nism(s) producing this problem remain unknown. To determine whether
capillary permeability is increased in women with PIH, the disappear-
ance rate of Evans Blue dye (EBDR) was determined in 18 women with
PIH, 17 third trimester normotensive primigravidas (N), and 10 nor-
motensive non-pregnant women (NP). The plasma volume (PV) was
measured using Evans Blue dye and extracellular fluid (ECFV) and
interstitial fluid (ISFV) volumes from the disappearance curves of
injected mannitol. Normal pregnancy was accompanied by significant
increases from non-pregnant values in PV (24.5 3.7 (SD) vs. 17.8 2.8
mI/cm NP, P < 0.001), ECFV (82.9 12.2 vs. 67.9 11.1 mI/cm NP,
P < 0.01) and the ratio PV:ISFV (0.43 0.07 vs. 0.36 0.08 NP, P <
0.05) but no significant change in EBDR (slope —0.181 0.310 vs.
—0.276 0.184 NP). In PIH plasma volume was reduced from normal
pregnancy (21.1 5.0, P < 0.05), ECFV was unchanged by PV:ISFV
was decreased (0.33 0.09, P < 0.01) and EBDR more rapid (—0.511
0.364, P < 0.01). However, there was no significant correlation
between PV and either EBDR or serum albumin. Women in N and PIH
groups with edema had greater ECFV, ISFV and EBDR than those
without edema but the differences were not statistically significant.
These data demonstrate that, as a group, women with PIH have
increased capillary permeability which may reduce plasma volume and
revert their distribution of extracellular fluid back to that of the
non-pregnant state. However, other factors must also work to produce
this fall in maternal plasma volume in a significant subset of women with
PIH.
Hypermetabolism in the remnant kidney (RK). D.C.H. Harris, Y.O.
Tay, S. Toma, Renal Laboratory, Westmead Hospital, Westmead NSW
2145, Australia. The rat RK model of chronic renal failure (CRF) is
hypermetabolic, and this hypermetabolism, at least with lactate as the
substrate, is accounted for mainly by processes which are independent
of sodium transport (Am J Physiol 254:F267). To characterize this
hypermetabolism further, RK and normal kidneys (N) were perfused
with a variety of substrates and the rates of various nontransport
metabolic processes determined. RK were examined 4 weeks after
partial nephrectomy, when hypertrophy had increased viable kidney
weight to normal (1.37 0.08 vs. 1.33 0.10 g, RK vs. N, a 5EM),
despite the surgical ablation of two-thirds of the nephron population.
With all substrates tested a greater proportion of whole kidney oxygen
consumption (Q02) was consumed in processes independent of net
sodium reabsorption (TNa/QO2) was lower in RK than N (e.g., 5 mM
glucose, 5.67 1.20 vs. 22.50 3.38, P < 0.001). Initial (1.20 0.23 vs.
0.63 0.13 mol/g/min, P < 0.05) and early (0.76 0.13 vs. 0.44 ±
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0.08, P < 0.05), but not steady state rates, of whole-kidney ammonia
(NH3) production were higher in RK than N. With 5 m glucose (G) as
substrate, initial (4.16 1.35 vs. 0.67 1.15 mol/min/g, P < 0.001),
early (4.00 0.74 vs. 0.93 0.36, P < 0.002) and steady state (2.52
0.15 vs. 1.57 0.20, P < 0.001) rates of whole-kidney G consumption
were higher in RK than N. Whole-kidney 0 production was similar in
RK and N. In conclusion, nephron NH3 and G production, and G
consumption are much higher in RK than N. We hypothesize that: (1)
as compensatory hypertrophy is mainly a proximal tubular process and
glycolysis in N is confined to the distal nephron, there is a loss of the
usual compartmentalization of metabolic processes in RK; and (2) this
nontransport hypermetabolism enhances disease progression in this
model of CRF.
Effects of calcium and vitamin D on blood pressure in conscious sheep.
J.J. Tresham, P. McGuire, J.P. Coghlan, J.A. Whitworth, B.A. Scog-
gins, Howard Florey Institute of Experimental Physiology and Medi-
cine, University of Melbourne, and Department of Nephrology, Royal
Melbourne Hospital, Victoria, 3050, Australia. There is a large litera-
ture on abnormalities of calcium metabolism in hypertensive animals
and man. This study examined the hypothesis that acute rises in plasma
Ca concentration will increase blood pressure, whereas long-term
dietary calcium loading will reduce the blood pressure of hypertensive
animals. The metabolic and hemodynamic effects of elevating plasma
calcium levels were examined in both normal and ACTH-hypertensive
sheep (N 4). Six weeks of dietary Ca + supplementation (150
mmol/day) did not alter plasma calcium levels, blood pressure or heart
rate, Five days of CaC12 infusion (2 mmol/hr) or intravenous vitamin D
injections (200 ng/kg/day) elevated plasma ionized and total Ca + levels
and heart rate, but mean arterial pressure was unchanged. As in other
species, elevation of plasma Ca levels over 4 hours by infusion of
CaC12 at 2, 5 and 10 mmol/hr increased mean arterial pressure and
decreased heart rate. The course of ACTH-induced hypertension was
not altered in animals supplemented with CaCI2 in their drinking water
for 6 weeks nor by intravenous injection of vitamin D for 5 days. This
study does not support a major role for altered plasma ionized or total
Ca + levels in the genesis of ACTH-dependent hypertension in the
sheep.
Cyclosporin A (CsA) treatment in focal and segmental hyalinosis and
sclerosis (FSHS): A controlled trial. R.G. Walker, P. Kincaid-Smith,
Department of Nephrology, Royal Melbourne Hospital, Victoria 3050,
Australia. Nine patients with biopsy proven FSHS and steroid resistant
nephrotic syndrome were allocated at random to treatment with CsA (5
to 8 mg/kg/24 hr) or no treatment for a period of 4 to 6 weeks and then
crossed over for the subsequent 4 to 6 months to the other group.
Warfarin, which is used in all nephrotic patients, was continued through
both treatment periods. Serum creatine levels increased at a similar rate
in treated and control patients, Serum albumin levels increased (P <
0.05) and urinary protein excretion decreased (<0.025) during CsA
therapy compared to the control period. No patient had complete
resolution of the nephrotic syndrome during the treatment period, but in
one patient continued on CsA for 18 months after the trial, the nephrotic
syndrome appears to have resolved. In this patient urine protein fell
from levels of 9 to 10 g124 hrs to a level of 1.03 g124 hrs after 18 months
of treatment, and serum albumin rose from 26 to levels above 30 g/liter.
Refractory gross edema which had accompanied the nephrotic syn-
drome in this patient for 3 years prior to treatment disappeared.
Conclusion. This trial demonstrates some benefit in this condition in
which no previous treatment has been effective. Experience in one
patient suggests that a controlled trial of prolonged treatment with CsA
may be indicated.
Polymorphonuclear (PMN) neutrophils infiltrate glomeruli in active
IgA nephropathy. P. Kincaid-Smith, K. Nicholls, I. Birchall, Depart-
ment of Nephrology, Royal Melbourne Hospital, Victoria 3050, Aus-
tralia. During episodes of macroscopic hematuria, patients with IgA
nephropathy commonly have PMN as well as fibrin and monocyte/
macrophages in glomerular capillaries. We quantitated PMN and mac-
rophage infiltration in glomeruli of patients with IgA nephropathy who
had undergone biopsy within 30 days of macropscopic hematuria.
Control patients had IgA nephropathy with urinary RBC counts
<50,000/ml at biopsy. PMN were quantitated using the monoclonal
antibody FMC 10 and monocyte/macrophages by HAM 56. Two








PMN/Glomerulus 0.13 0.03 1.10 020b
% Glom. +ve PMN 10.5 2.8 45.9 3.4'
Monocytes/Glomerulus 0.59 0.14 1.58 0.20a
% Glomeruli +ve,
fibrin 0 10.0 20b
% Glomeruli with
crescents 0 16.5 2•2b
No patients with
crescents 0/22 45/54
a P < 0.01
b p < 0.001
We conclude that PMN as well as monocytes are present and presum-
ably participating in glomerular injury in active mesangial IgA nephrop-
athy.
Expression of complement 3 receptors (CR! and CR3) on neutrophils
and erythrocytes in patients with IgA nephropathy. K. Tao, K. Nicholls,
S. Rockman, P. Kincaid-Smith, Departments of Nephrology & Hae-
matology, Royal Melbourne Hospital, Victoria 3050, Australia. The
expression of C3 receptors (CR1 and CR3) on neutrophils (PMN) were
measured in 26 patients with IgA nephropathy (IgAN), 17 normal
persons and 8 patients with non-IgA glomerulonephritis (non-IgA GN)
by fluorescence-activated cell sorting after labelling with monoclonal
antibodies. Mean channel fluorescence for CR1 and CR3 on PMN were
significantly higher in IgAN patients than in both control groups (P <
0.01). (CR1 mean SD 42.5 10.4 in IgAN 31.7 11.5 in normal
controls, 27.8 9.0 in non-IgA GN; CR3 94.0 16.5, 75.0 16.6 and
76.7 15.6, respectively). No differences were found between the two
control groups or between IgAN patients with normal and impaired
renal function. These results imply that PMN are activated in IgAN
patients. The expression of CR1 and CR3 on PMN may be up-regulated
by immune complexes (ICs) enhancing both phagocytosis of C3b- or
iC3b-coated particles and absorptive pinocytosis of soluble ICs con-
taining C3b or iC3b. Erythrocyte CR1 and CR3 expression was mea-
sured by ELISA and found to be slightly but significantly lower in IgAN
patients than in the other 2 groups (CR1 85.3 28.4 in IgAN, 113.1
28.8 in normal controls, 109.4 28.2 in non-IgA GN, P < 0.02; CR3
80.9 20.0, 100.4 19.9, 101.2 24.9 respectively, P < 0.05).
Complement-dependent clearance of IC-IgA is supposed to be reduced.
Platelet factor 4 labelling of hyaline deposits in arterioles and glomer-
ular capillaries in diabetes. M. Nakajima, T. Hewitson, D. Mathews, P.
Kincaid-Smith, Department of Nephrology, Royal Melbourne Hospi-
tal, Victoria, 3050 Australia. Renal biopsy tissue from 17 patients with
diabetes was fixed in periodate-lysine-paraformaldehyde, post fixed in
osmium and immunolabelled with protein A-gold complex solution
according to the method of Tanaka et al (Cancer Res 44:3483—3504,
1984). The ultrastructure of arterioles and glomerular capillaries
showed that hyaline deposits can be intensely labelled with antisera
against platelet factor 4 (PF4). In all cases that hyaline material was
identified in arterial walls, PF4 labelling was intensely positive. In 3
cases where so-called exudative or fibrin cap lesions were identified in
glomerular capillaries, PF4 was also positive. Capsular drop lesions,
which Kimmelsteil regarded as specific for diabetes, also showed
intense PF4 labelling, as did smaller hyaline deposits in Bowman's
capsule. Platelet thrombi were identified in glomerular capillaries in 3
cases. Where intact platelets were examined, PF4 was localized in the
alpha granules. In 1 additional case a "thrombus", without distinct
platelet walls, was intensely labelled with PF4, suggesting that this
could represent an intermediate stage between clear-cut platelet
thrombi and hyaline deposits. In 2 cases of primary focal and segmental
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hyalinosis and sclerosis, hyaline deposits showed the same intensity of
labelling with PF4 as those hyaline deposits seen in diabetes. In 9 cases,
microspherical particles were identified in glomeruli and were also
intensely labelled with PF4.
Platelet factor 4 labelling of mesangial deposits in mesangial IgA
glomerulonephritls. M. Nakajima, T. Hewitson, D. Mathews, P.
Kincaid-Smith, Department of Nephrology, Royal Melbourne Hospi-
tal, Victoria 3050, Australia. Renal biopsy tissue from 8 patients with
mesangial IgA glomerulonephritis was fixed in periodate-lysine-para-
formaldehyde, post-fixed in osmium, and immunolabelled with protein
A-gold complex solution according to the method of Tanaka et al
(Cancer Res 44:3483—3504, 1984). The ultrastructure of the mesangium
was studied on serial sections stained with antisera against platelet
factor 4 (PF4), beta-thromboglobulin, platelet glycoprotein lib-Illa
complex and fibrinogen and compared with serial sections labelled with
antisera against IgA, IgG, 1gM and C3. Intense and uniform immu-
nogold labelling of mesangial deposits with antiserum against PF4 was
observed in all 8 cases, and in 3 cases FF4 labelling was as intense as
IgA labelling. Fibrinogen labelling was also uniformly present in mesan-
gial deposits while all other antisera displayed either weak or negative
labelling. Free platelets were detected in glomerular capillaries in serial
sections in 5 of 8 biopsies. All demonstrated positive labelling of PF4,
beta-thromboglobulin and fibrinogen in alpha granules. Glycoprotein
lIb-Illa complex labelling was definitely positive in 3 and probably
positive in 2 cases. The invariable deposition of PF4 and fibrinogen in
these biopsies suggests that mesangial deposits could be the result of
activation of intraglomerular coagulation. Mesangial IgA glomerulone-
phritis could have been called platelet factor 4 glomerulonephritis had
Berger used antisera against platelet factor 4 in 1968.
Late phase of acute cisplatin nephrotoxicity: Evidence for inhibition of
the sodium pump. M.J. Field, T.E. Bostrom, A.Z. Gyory, Department
of Medicine and EM Unit, University of Sydney, NSW 2006, Australia.
Our previous studies on the mechanism of acute cisplatin nephrotoxic-
ity indicated that inhibition of Na entry into proximal tubule cells
occurred in the earliest phase of this insult. In the present study,
electron microprobe X-ray analysis (EMPX) was used to study cell
composition changes associated with the later phase of renal damage
induced by this agent. Wistar rats were given an i.v. injection of
cisplatin (5 mg/kg) and studied by a sequential clearance/EMPX proto-
col 4 days later. An uninjected control group was studied similarly.
Cisplatin-treated rats showed a progressive rise in blood urea from day
2 after the injection, and had a significantly reduced GFR (58 11
d/min/l00 g) compared to controls (507 14) at the time of the
clearance study. Excretion data for Na and K showed that external
balance for these ions was attained in the treated group of animals, but
the fractional excretion of each was significantly higher in the treated
group. Freeze-dried cryosections were prepared from quench-frozen
kidneys obtained from animals in both experimental groups, and these
were analyzed using energy-dispersive EMPX (N = 111 proximal cells
in control, 96 in cisplatin). This revealed significantly higher concen-
trations of Na (27.6 1.2mmol/kg wet weight) and Cl (33.5 1.3) in the
cells from cisplatin-treated kidneys compared with the controls (22.2
0.6 and 22.2 0.5, respectively). When element analyses were ex-
pressed in units of mmol/kg dry weight, in order to eliminate the effect
of cell volume changes, significant rises were still found after cisplatin
in cell Na (24%) and Cl (33%), while K content was unchanged. We
interpret these results to mean that during the late phase of acute
cisplatin nephrotoxicity, the activity of the cell Na pump is inhibited,
although an increase in entry of Na into the cell cannot be excluded.
Treatment of refractory hyponatremia in hospitalized patients using
oral urea. G. Luxton, J.R. Lawrence, M.J. Field, Department of
Medicine, University of Sydney at Concord Hospital, NSW 2139,
Australia. Hyponatremia is a common problem in hospitalized patients
suffering from severe edematous disorders, inappropriate secretion of
ADH (SIADH), and some endocrine conditions. Treatment with water
restriction is often poorly tolerated or ineffective in restoring plasma
osmolality to normal, and other therapies are frequently unsuccessful or
unsafe. To explore the potential of oral urea as a means of treating
hyponatremia, we have studied 7 patients with a plasma sodium
concentration less than 130 mmol/liter which was refractory to treat-
ment with supervised water restriction. Five subjects were male and 2
female, and their ages ranged from 69 to 82 years. Underlying clinical
conditions were diverse, including 2 patients with classical SIADH due
to cerebral disease or injury, I case each of hypothyroidism and
congestive heart failure, and 3 cases with multifactorial etiology. Initial
plasma Na at the time of referral was 121 3 mmol/liter (mean SEM),
plasma osmolality was 253 6 mOsm/kg, and creatinine was 0.08
0.01 mmol/liter. Urinary osmolality was 464 79 mosm/kg and urinary
Na was 64 19 mmollliter. Measurement of plasma ADH (N = 5)
showed incomplete suppression in relation to the simultaneous plasma
osmolality. After a period of water restriction (500 to 750 mI/day) and
optimal treatment of the underlying condition, there was no significant
change in plasma Na (119 3 mmollliter). Patients were then given oral
urea, 10 or 15 g 8-hourly, prepared freshly in 50 to 100 ml water and
flavored to disguise the taste. In most cases, water restriction was
relaxed during this therapy. A beneficial response occurred in 6 of the
7 patients, the plasma Na rising significantly to 134 1 mmollliter (P <
0.01 compared to previous values), accompanied by an improvement in
mental functioning. At the same time, plasma urea rose from a
pretreatment value of 5.3 1.0mmol/liter to 13.7 1.9mmol/liter (P <
0.01). The treatment was well tolerated by all subjects, and was free of
toxicity or side effects. We conclude that treatment with urea by mouth
is of benefit in the management of hyponatremia of a variety of
etiologies, where water restriction alone is ineffective.
Diuretic-induced hyponatremia: Role of impaired tubular sodium
transport versus ADH-mediated water retention. M.J. Field, F. Seow,
JR. Lawrence, Department of Medicine, University of Sydney at
Concord Hospital, NSW 2139, Australia. To determine the origins of
diuretic-induced hyponatremia, we conducted simultaneous clearance
and free-flow micropunture experiments in homozygous Brattleboro
rats with hereditary deficiency of ADH. Group 1 rats received no drugs
or hormone replacement; Group 2 were given hydrochlorothiazide (750
g/hr/l00 g) plus amiloride (60 g/hr/100 g) during the clearance
protocol; Group 3 were given ADH treatment as dDAVP (0.2 gIday)
for 10 to 12 days prior to and during the experiment; and Group 4
received both the diuretic drugs and the ADH replacement. Clearance
and micropuncture data were collected during hypotonic Ringer infu-
sion. PlasmaNainthe4respectivegroupswas 146 1,139 1,141
I and 133 I mmol/liter, all differences (except Gp 2 vs. Gp 3) being
significant (P < 0.05). Free water clearance was greatest in Gp 1(6.4
1.3 pi/min/l00 g), essentially zero in Gp 2 (1.3 0.9), and negative in
Gps 3 (—5.6 0.5) and 4 (—10.8 0.6). Sodium excretion, both
absolute and fractional, was greatly stimulated by diuretic treatment,
but in the presence of the diuretics, it fell 30% with the addition of ADH
(Gp 2 vs. Up 4, P < 0.05). Micropuncture data revealed that diuretic
treatment effectively abolished Na reabsorption along the distal tubule,
while being without effect on water transport in this segment (Gps I vs.
2 and 3 vs. 4). ADH, on the other hand, increased water reabsorption
between the late proximal and early distal sites in the absence of
diuretics (Op I vs. Op 3), and between the late distal tubule and the final
urine both with and without diuretic treatment. The Na retaining effect
of ADH was not significant up to the late distal puncture site, suggesting
an effect on Na transport at deeper nephron sites. We conclude: 1)
significant hyponatremia develops after combination distal diuretic
therapy only if ADH is present; 2) diuretic inhibition of Na transport,
and ADH effects, are of approximately equal importance in producing
this hyponatremia; 3) chronic ADH therapy may promote Na retention,
but its water conserving effect is greater, and contributes to hypona-
tremia during diuretic therapy by dilution.
Early changes in GFR following induction of diabetes mellitus (DM) in
Sprague-Dawley (SD) rats. C.A. Pollock, J.R. Lawrence, M.J. Field,
Department of Medicine, University of Sydney at Concord Hospital,
NSW 2139, Australia. To evaluate acute changes in GFR associated
with induction of DM, we have employed a technique for daily
measurement of GFR in unrestrained SD rats using clearance of C14
inulin continuously infused s.c. via an osmotic minipump. This tech-
nique of measurement of GFR was validated by clearance of intrave-
nously infused inulin using standard methods (N = 12; r = 0.94).
Baseline GFR was determined for 4 days prior to iv. injection of either
60mg/kg streptozotocin (STZ) in citrate buffer (N = 12), or buffer alone(N = 3). All rats were initially normoglycemic, and all STZ-injected
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animals developed DM. Seven rats developed severe hyperglycemia
(BSL > 18 mmollliter, Group 1), while in 5 the blood glucose was
moderately elevated, with or without insulin treatment (BSL 13 to 18
mmol/liter, Group 2). Rats injected with buffer alone remained normo-
glycemic (BSL 7.5 1.7, Group 3). Group 1 rats had a sustained
increase in GFR appearing within 24 to 48 hrs of STZ administration,
and persisting for at least 10 days (1.00 0.05 vs. 1.29 0.05
ml/min/l00 g; P < 0,005), whereas in Group 2 no change in GFR was
observed up to 10 days following the development of DM (1.15 0.03
vs. 1.10 0.08). Group 3 showed no change in GFR (1.10 0.03 vs.
1.09 0.06). Micropuncture studies performed after 10 days of DM
demonstrated an elevation in single nephron GFR measured in both
proximal and distal tubules, being 103.9 10.5 and 45.7 9.2 nI/mm,
respectively, in Group 1 rats, 64.9 5.6 and 34.6 3.4 nI/mm in Group
2, and 46.6 3.2 and 32.1 4.4 nI/mm in Group 3. This study shows:
1) GFR may be accurately measured on a continuous basis; 2) an
elevation in whole kidney and single nephron GFR occurs at the time of
induction of DM when the hyperglycemia is severe; 3) this hyperfiltra-
tion may be blunted at least in the short term with partial control of
hyperglycemia.
Hereditary magnesium losing nephropathies. D.A. McCredie, Depart-
ment ofPaediatrics, University of Melbourne, Royal Children's Hos-
pital, Melbourne, Australia 3052. Considerable confusion exists in the
literature with regard to magnesium losing nephropathies. At least three
conditions are defined: (i) familial hypokalemia and hypomagnesemia
(Gitelman's syndrome), (ii) familial hypomagnesemia with hypercalci-
uria, and (iii) isolated familial hypomagnesemia of renal origin. In
addition Bartter's syndrome (hereditary potassium losing nephropathy
with growth retardation, urinary concentrating defect and juxtaglomer-
ular hyperplasia) may sometimes be associated with hypomagnesemia.
Gitelman's syndrome is frequently misdiagnosed as Bartter's syndrome
because of their common presentation as potassium losing renal dis-
ease. However the clinical presentation is completely different, many
patients with Gitelman's syndrome being completely asymptomatic or
presenting with minor tetanic symptoms. Moreover there is less acti-
vation of the renin-angiotensin-aldosterone system in Gitelman's syn-
drome, while hypocalciuria is the rule (as compared with the hypercal-
ciuria of Bartter's syndrome). Features of seven patients with
Gitelman's syndrome, four with Bartter's syndrome and two with
familial hypomagnesemia with hypercalciuria will be presented with
particular reference to their differential diagnosis, pathophysiology and
natural history of the disease over a course of up to thirty years.
Effects of marine fish oil (MaxEpa) on serum lipoproteins in hemodi-
alysis patients. G.A. Love!!, PD. Boyle, S.J. Fleming, M.J. Thomas,
Conjoint Internal Medicine Laboratory, Royal Brisbane Hospital,
Brisbane, Q4029, Australia. Hyperlipidemia (HL) is a commonly ob-
served metabolic complication in renal failure patients on hemodialysis.
The predominant lipid pattern corresponds to type IV HL, which is a
recognized atherosclerotic risk factor and implicated in the high mor-
tality rate from cardiovascular disease found in this group. Since recent
studies have shown omega-3 fatty-acids (MaxEpa) are of benefit in
treatment of primary HL, we have investigated their use in hemodial-
ysis patients. Twenty subjects with initial serum triglyceride values 2
mmol/liter participated in a study of randomized, placebo-controlled,
double-blind crossover design. Either MaxEpa or placebo (olive oil)
was taken (10 g/day) during the first treatment period (3 months)
followed by the alternative treatment in the second period. Monthly
fasting blood samples were assayed for total cholesterol (chol), triglyc-
erides, HDL-chol, LDL-chol, apolipoprotein (apo) A-i and apo B.













Placebo 3.88 2.91 6.12 1.48 1.21 0.12 1.46 0.50
MaxEpa 2.88 1.33 6.27 1.31 1.11 0.17 1.41 0.29
P < 0.01 NS 0.01 NS
We conclude that MaxEpa has produced a significant decrease in serum
triglycerides within our group and shows potential for its beneficial use
with hemodialysis.
Proteinuria in the isolated perfused kidney. W.D. Comper, M. Tay, T.
Knight, L. Pratt, E.F. Glasgow, M.S. Baker, Departments of Biochem-
istry and Anatomy, Monash University, Clayton, Victoria, 3168, AuS-
tralia. We studied isolated kidney perfusion characterized by the onset
of heavy albuminuria after 2 hr perfusion with 5% Cohn fraction V
albumin in modified Krebs-Henseleit buffer, 95% O2-% CO2 (protein
excretion rate of 230 73 g min kidney, N = 8). This was
accompanied by only small changes in low molecular weight protein
clearance and fractional clearances of [3H]-dextrans with Stokes-
Einstein radii in the range of 18 to 45 A. Significant decreases in the
fractional clearance of dextrans with radii >45 A were observed,
however. Electron microscopical analysis indicated that the basement
membranes and foot processes were normal. The 2 hr perfusion was
accompanied by metabolic changes which included an approx. 50%
reduction in total ATP levels (P < 0.01) as compared to completely
ischemic kidneys where ATP levels were reduced by 80% in one
minute, and a 2 to 3-fold increase (P < 0.01) in the xanthine oxidase
levels in relation to the total xanthine dehydrogenase plus xanthine
oxidase levels. We have demonstrated that a mixture of oxygen
metabolite scavengers containing mannitol, superoxide dismutase and
catalase included in the perfusion medium significantly reduced protein
excretion by 60% (P < 0.01 df = 7 for comparison of means with
unequal variance) to give protein excretion rates of 102 30 g min1
kidney (N = 8). Studies on the use of the individual scavengers
indicated no significant differences with the control, although allopuri-
nol yielded enhanced protein excretion values. The scavengers had no
significant effect on other standard renal parameters. These results
suggest that reactive oxygen metabolites may be involved in predomi-
nant damage to glomerular filter function as a result of partial ischemia
produced during perfusion.
Alteration of glomerular angiotensin II receptor density during the
course of anti-glomerular basement membrane (GBM) nephritis. V.
Timmermans, J. Charlesworth, G. Macdonald, P. Peake, Department
of Nephrology, Prince Henry Hospital, Sydney, NSW, Australia.
Immunological damage in human and experimental forms of glomeru-
lonephritis may induce structural and/or functional changes in glomer-
ular angiotensin II receptors (AIIR) and, thus alter regulation of
intrarenal hemodynamics. This possibility was examined in rats follow-
ing the induction of glomerular injury by the injection of sheep anti-rat
GBM antibody. Control animals received normal sheep globulin or
aggregated IgG. Rats were killed at selected times over the next eight
weeks and AIIR on isolated glomeruli were quantitated by Scatchard
analysis using (Sar'-118) All. Plasma All levels were also measured at
this time. Significant down-regulation of AIIR was observed sixteen
hours after the administration of the nephrotoxic antibody—there was a
mean decrease in AIIR from 96 9 x 10 to 50 7 X 10 receptors/
glomeruli ( SEM, p0.01) and a corresponding increase in plasma All
(24 5 vs. 67 21 pg/mi, P < 0.01). The receptor number then
increased as the disease progressed. After three days AIIR was
significantly greater than in normal controls, (150 12 x 106 receptors!
glomeruli, P < 0.001), while plasma All levels fell to <5 pg/ml. Over the
next six weeks there was a gradual return to AIIR expression to control
values, but the circulating All remained <5 pg/mI. There was no change
in binding affinity. Administration of non-nephrotoxic antibody had no
effect while aggregated IgG caused a slight reduction in AIIR. The data
suggest that the early changes in ALIR are a specific result of antibody
fixation and immune activation. The change in AIIR and plasma All
later in the disease may indicate either true dysfunction in receptor
setting or suggest intra-renally generated All as an important regulator
of glomerular AIIR expression.
Recombinant erythropoietin (EPO) therapy in chronic hemodialysis
patients is frequently associated with macrocytosis. Michael C. Layer, E.
Paul MacCarthy, David H. Clyne, Victor E. Pollak, University of
Cincinnati Medical Center, Cincinnati, Ohio, USA. Thirty-four patients
entered one of two studies of the use of EPO in anemic chronic
hemodialysis patients and have been followed for up to 14 months. Of
the 23 patients still active in the studies, 8 have developed marked
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macrocytosis (mean MCV 109.8 range 101 to 120). This is independent
of the reticulocytosis and occurs later in the course of therapy when the
peak reticulocyte response has passed. The mean reticulocyte count
was 2.5% at the time of the maximum MCV. Serum levels of Vitamin
B12 and folic acid were normal and other causes of macrocytosis (such
as liver and thyroid disease) were absent. The macrocytic group did not
differ from the remainder with respect to response to EPO or the dose
required to attain this response. They were clinically the same as the
non-macrocytic group in all parameters measured. The cause of this
phenomenon is unclear. A pharmacologic effect of EPO is unlikely as it
does not occur in all patients and is not dose related. Further studies of
this phenomenon may give insights into the physiological and therapeu-
tic characteristics of EPO.
Regulation of renin synthesis during sodium depletion. G.L. Barrett,
T.O. Morgan, D. A/corn, Departments of Physiology and Anatomy,
University of Melbourne, Victoria 3052, Australia. We have investi-
gated the role of the macula densa and beta adrenergic receptors in the
stimulation of renin synthesis in the mouse kidney during sodium
depletion. Propranolol was used to block beta receptors, and the
hydronephrotic kidney model was used to exclude macula densa
effects. Eight weeks after ureteral ligation, there was complete atrophy
of tubules while vascular elements were preserved. When mice with
normal kidneys were given a low-sodium diet for 7 days following a
frusemide bolus, there was a 470% increase in plasma renin concentra-
tion (PRC), (P < 0.01), and a 87% increase in renal renin content (P <
0.05). The addition of propranolol did not significantly alter the in-
creases in PRC or renal renin. The same sodium depletion regime was
given to mice which had a hydronephrotic kidney and a normal
contralateral kidney. PRC increased by 430% in these mice (P < 0.01).
Renal renin increased by 93% in the contralateral kidney (P < 0.03) and
by 77% in the hydronephrotic kidney (P < 0.05). Renal renin mRNA
increased by 167% in the contralateral kidney and by 276% in the
hydronephrotic kidney. The addition of propranolol did not cause
significant changes in PRC, renal renin or renin mRNA in these mice
during sodium depletion. Thus, removal of the effects of beta stimula-
tion and the macula densa, either alone or in combination, did not
reduce the stimulation of renin synthesis during sodium depletion. This
suggests that the intra-renal baroreceptor or other factors may mediate
the response of juxtaglomerular cells to sodium depletion.
Morphological analysis of cultured rabbit renal parenchymal explants.
C.J. Roe, R. Whitehead, R.G. Walker, I. Birchall, P.S. Kincaid-Smith,
Department of Nephrology and Ludwig Institute for Cancer Research,
Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia. The
study of renal tubulointerstitial disease would be aided by an in vitro
model in which the relationship between tubular epithelium, tubular
basement membrane (TBM) and extracellular matrix is maintained. We
have developed such a system the light and phase contrast microscop-
ical morphological features of which are described. Dissected pieces of
NZW rabbit renal parenchyma were suspended in collagen gels and
bathed in RPMI 1640 medium containing 10% FCS, I g/ml hydrocorti-
sone, 0.6 g/ml insulin, IO M a-thioglycerol, 50 IU penicillin, 50 IU
streptomycin, JO ng/ml EGF and incubated at 37°C in 5% CO2 in air for
17 days. Cultures were assessed dialy by phase contrast microscopy
and histologically at the termination of the experiment. Phase contrast
microscopy: Tubules demonstrated a fine granularity and glomeruli
could be distinguished as red spheres. Budding of the explant and a
monolayer outgrowth of tightly packed polygonal cells occurred. His-
tology: Acute tubular necrosis was followed by regeneration and
re-epithelialization of the tubules. Glomeruli demonstrated collapsed
capillary loops. During the second and third weeks in culture tubules
were lined with a single layered epithelium on an intact TBM. Intralu-
minal casts of cellular debris were present. Cuboidal, polygonal,
columnar and occasional spindle shaped populations of lining tubular
epithelial cells were observed. The interstitium was enlarged by an
homogenous material. This system may be used during the early culture
period as a model of tubular necrosis and during the late culture period
for the study of the effects of added nephrotoxins or cystogens.
Sodium: A regulator of vasoactive intestinal peptide (VIP) metabolism.
G.M. Hawley, S. Shelley, K.A. Duggan, G.J. Macdonald, Department
of Nephrology, Prince Henry Hospital Little Bay, N.S. W. 2036, Aus-
tralia. Intragastric sodium loading in rabbits on salt restricted diets has
been shown to release VIP (a natriuretic hormone) and to reduce its
hepatic metabolism. To establish the relative contributions of chronic
sodium intake and acute sodium loading to this decrease in metabolism
we determined the metabolic clearance rates (MCR) of VIP in rabbits
on normal and low sodium diets before and after an acute gastric
sodium load. Rabbits with chronic portal catheters and gastrostomies in
situ were equilibrated on normal and low sodium diets. VIP (10 pmol
kg' min) was infused via the marginal ear vein or portal vein in
random order for 50 minutes in conscious rabbits, and blood was
sampled to determine basal and steady state levels of VIP. The
experiments were then repeated 30 minutes after an acute sodium load
of 1.5 mmol kg' given intragastrically. Salt restriction increased MCR
of VIP (150 to 340 ml kg' min, P <0.001), while administration of
an acute gastric sodium load resulted in significant reduction in hepatic
MCR of VIP in both salt restricted (510 to 270 ml kg min, P <
0.005) and normal groups (590 to 360 ml kg min1, P < 0.025). We
conclude, therefore, that both chronic sodium intake and acute salt
loads modify the metabolism of this natriuretic peptide.
Functional and structural characteristics of the CD13 molecule. P.J.
O'Connell, A.J.F. d'Apice, Department of Nephrology, Royal Mel-
bourne Hospital, Victoria 3050, Australia. There is increasing evidence
that exocytosis of proteases and production of reactive oxygen species
are important in the pathogenesis of glomerulonephritis and tubuloin-
terstitial . Neutrophils, monocytes and endothelium are all capable of
generating reactive oxygen species, and in addition the leucocytes
cause damage by protease exocytosis. Perturbation of the CD13 mole-
cule, which is present on all 3 cell types, has been shown to induce the
respiratory burst and exocytosis. The natural ligand for CDI3 is not
known. In the course of studying endothelial cell surface molecules a
CD13 specific monoclonal antibody (mAb), RMAG6, was raised. The
CDI3 specificity of RMAG6 was demonstrated by its identical patterns
of reactivity as other CDI3 mAb (in particular, WM15) and its reactivity
with mouse L-cells transfected with the CDI3 genome. WM15 and
RMAG6 immunoprecipitate molecules of identical molecular size and
isoelectric point and have identical peptide maps. However, in preclear-
ing experiments, neither mAb was capable of depleting the reactivity of
the other, that is, the mAb recognize different molecules, indicating that
there must be at least two species of CD13 molecules. All other CDI3
mAb could be grouped as RMAG6-like or WM15-like. Tunicamycin
treatment of cells blocks N-linked glycosylation and results in expres-
sion of a deglycosylated CD13 molecule. Neither RMAG6 or WMI5
could bind tunicamycin treated cells, indicating that their epitopes are
N-linked sugars. Desialation with neuraminidase failed to distinguish
the two species and studies with other endo- and exoglycosidases are in
progress. Functional studies showed that RMAG6 and WM15 inhibited
complement receptor 3(CR3) binding of C3bi and this was partially
reversed by trypsin inhibitor indicating that perturbation of both CD13
species cause exocytosis of serine proteases. In summary, CDI3 has
been shown to exist as two molecular species both of which can mediate
serine protease exocytosis.
Glomeruloscierosis after 5/6 nephrectomy in Milan hypertensive and
normotensive rats. M. El-Khatib, G. Becker, R. Walker, P. Kincaid-
Smith, Department of Nephrology, Royal Melbourne Hospital, Victo-
ria 3050, Australia. In most experimental rat models hypertension
conveys an increased risk of age-related proteinuna and focal and
segmental glomerulosclerosis (FGS). However, it has been reported
that spontaneous FGS develops more slowly in Milan hypertensive rats
(MHS) than in Milan normotensive rats (MNS); both strains being
originally derived from the same strain and inbred for high or normal
blood pressure. We compared the rate of development of FGS in MHS
and MNS rats after subjecting the animals to 5/6 nephrectomy (Nx) at
13 weeks of age. Fifteen MHS and 19 MNS rats survived beyond 1
week post-Nx. Animals were sacrificed for histology when uremic; half
the survivors were sacrificed at 13 weeks, the remainder when uremic
or at 26 weeks post-Nx. At all times MHS 5/6 Nx animals had
significantly higher blood pressure than MNS 5/6 Nx animals. In MNS
5/6 Nx rats proteinuna and plasma creatinine and urea concentrations
increased rapidly after 8 weeks post-Nx, and survival was greatly
reduced (median 9, range 8 to 19 weeks post-Nx) compared with MHS
5/6 Nx rats, all of whom survived longer than 17 weeks post-Nx, and all
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but one beyond 19 weeks post-Nx. MHS 5/6 Nx animals showed no rise
in plasma creatinine, urea, or proteinuria in the first 13 weeks post-Nx.
Analysis at 13 weeks showed FGS in all MNS 5/6 Nx animals, and only
glomerular hypertrophy and some interstitial fibrosis in MHS 5/6 Nx
animals. In conclusion, MHS rats, although they have a higher blood
pressure than MNS rats, do not develop FGS as rapidly in response to
5/6 Nx. This may be due to narrowing of pre-glomerular arteries in
MHS, or other genetically dictated strain differences.
Aminoguanidine prevents accumulation of advanced glycosylation end-
products (AGE) in renal basement membranes of diabetic mice. K.
Nicholls, T. Mandel, Department of Nephrology, Royal Melbourne
Hospital, and Transplantation Unit, The Walter and Eliza Hall Insti-
tute, Victoria 3050, Australia. The non-enzymatic reaction of glucose
and proteins initiates AGE production and may underly many abnor-
malities in diabetes mellitus. AGE may be measured by specific
fluorescence and inhibited by aminoguanidine. We studied the effect of
chronic aminoguanidine on renal basement membrane AGE accumula-
tion in untreated diabetes. We used 4 groups of female BALB/c mice,
initially aged 7 to 8 weeks, Group 1: STZ injected, 250 mg/kg i.v.;
Group 2: STZ injected, from Day 6 onwards, the animals received 50
mg/kg aminoguanidine once daily lIP; Group 3: aminoguanidine only;
Group 4: age-matched controls, At sacrifice (7 months), blood glucose,
HbAlc and AGE accumulation were assayed. Although blood glucose
and HbAlc were not different in the diabetic groups, Group I animals
had significantly greater AGE accumulation than Group 2:


































a p <0.01, vs. 2; b P < .001, vs. 3 or 4; P < .05, vs. 3 or 4
We conclude that aminoguanidine does prevent glycosylation of renal
basement membranes in this mouse model diabetes.
DetectIon and treatment of dialysis related amyloldosls. L.P. McMa-
hon. J.K. Dawborn, S.M. Evans, K.J. Pleszcynski, S.L. Woo, Renal
Unit, Department of Medicine, Austin Hospital, Heidelberg, Victoria
3084, Australia. Current methods of detection of dialysis related
amyloidosis (DRA) in long-term hemodialysis (HD) patients prior to the
onset of symptoms are imperfect, as in the means of reducing the load
of /32-microglobulin (/32m) which has been strongly associated with the
development of DRA in these patients. Twenty-seven long-term (>7
years) HD patients (incltiding three with known DRA) and 28 controls
were assessed by symptom evaluation (joint pain and stiffness), shoul-
der ultrasound (tendon diameters, bursae, tissue deposits), mTcMDP
bone scan 9 (uptake in large joints), joint X-rays (degenerative changes,
soft-tissue deposits), NCS (carpal tunnel syndrome) and various sero-
logical parameters (Al3, PTH, Cr, Hb, Fe studies and intra-dialytic
CRP levels). All evaluations apart from serology showed distinct
abnormalities in the amyloid group as well as in some long-term HD
patients without symptoms. Serum changes in /32m levels during HD
and hemofiltration (HF) were also compared in 5 different, highly
permeable membranes (acrylonitrile) (AN69) cellulose acetate, cuprom-
monium, cuprommonium rayon and polysulphone (PS) in 6 stable HD
patients. The greatest reduction was seen with the PS (51%) and AN69
(36%) membranes (P < 0.001); however, in both cases levels had risen
to 80% of initial values by the next dialysis. Serum changes showed a
close correlation with dialysate concentration (r = 0.93), but not with
membrane pore size nor sieving co-efficient. /32m levels were altered
markedly with HF (P < 0.001), but not with HD despite evidence of
continued removal with the latter. We conclude that shoulder ultra-
sound and SSmTCMDP bone scan may contribute to earlier detection of
DRA, that effective removal of 132m is possible with selected permeable
membranes, but that additional mechanisms appear responsible for
changes in pre-dialysis $m levels.
Post-transplant hypercalcemia. F.L. lerino, J.K. Dawborn, B.E.
Clarke, F. Mclnnes, V.H. Young, P.1. Miach, Departments of Medi-
cine, Anatomical Pathology, Biochemistry, Austin Hospital, Heidel-
berg, Victoria 3084, Australia. A study of post-transplant hypercalce-
mia (HC) was undertaken by analyzing clinical data of all patients
transplanted after 1983 with creatinine clearance >1 mI/sec and graft
survival >1 year (27 patients, Group A), and 6 similar patients with
persistent HC transplanted before 1983 (Group B). In Group A, 26%
had HC. The length of time on dialysis, pre-transplantation plasma
calcium, plasma phosphate, serum alkaline phosphatase (SAP) and
immunoreactive parathyroid hormone (iPTH) were not significantly
different, comparing HC and normocalcemic (NC) patients (all P >
0.05). After transplantation, iPTH returned to normal in all Group A
patients over a 3 to 5 year period. However, iPTH was inappropriately
high for the level of plasma calcium in HC patients, indicating parathy-
roid overactivity which was not suppressed. Persistent HC after one
year was the best predictor of long-term HC. All patients had a fall in
plasma phosphate, which was more marked in HC patients (P < 0.05).
SAP was elevated in the HC patients compared to NC patients and was
significantly different at 6 months (P < 0.01) and one year (P < 0.05),
suggesting increased osteoblastic activity related to bone healing. There
was evidence of radiological healing of osteitis fibrosa in 2 HC and 2 NC
patients. HC patients had a higher urine calcium, higher urine phos-
phate and lower tubular reabsorption of phosphate per 100 ml GFR (all
P < 0.001). Persisting hyperparathyroidism (HPT) in HC patients was
also suggested by the correlation between iPTH and SAP (P < 0.01),
urine phosphate (P < 0.05), and urine calcium (P = 0.05). Five patients
in group B had an elevated iPTH 5 to 10 years after transplantation and
4 patients underwent subtotal parathyroidectomy with biochemical
changes after surgery consistent with correction of HPT; one patient
treated conservatively remains hypercalcemic 9 years later. Morpho-
logically the parathyroid glands were enlarged (25- to 50-fold increase in
total mass) showing areas of diffuse and nodular hyperplasia, acinar
formation, hemorrhage, hemosiderin deposition, scarring, calcification
and cystic degeneration. Persistent HPT was the major factor contrib-
uting to HC. This may be due to failure of involution of enlarged
parathyroid glands despite good renal function and/or to alteration in
the set point for calcium regulation. Spontaneous resolution of HPT is
unlikely if HC is present 1 to 2 years after transplantation and thus
surgery should be considered at this stage.
Glomerular tumor necrosis factor (TNF) production in experimental
anti-GBM glomerulonephritis (GN). P.G. Tipping, T. W. Leong, S.R.
Holdsworth, Monash University Department of Medicine, Prince Hen-
ry's Hospital, Melbourne 3004, Australia. TNF is a potent inflamma-
tory mediator released by macrophages (Mo). In both human and
experimental proliferative GN, Mo are prominent mediators of injury.
The involvement of TNF in the mediation of injury in GN has not been
studied. To address this question, glomeruli were isolated from rabbits
developing Mo-dependent anti-GBM GN, and their glomerular TNF
production in culture was compared with TNF production by normal
rabbit glomeruli and glomeruli isolated from rabbits developing a Mo
independent model of GN. TNF was bioassayed in a standard L929
fibroblast cell cytotoxicity assay. Glomerular TNF production (U/b3
gloms/24 hr) was: Mo dependent GN 1.15 0.10 (mean 5EM); Mo
independent GN 0.03 0.01; and normal glomeruli 0.01 0.01. TNF
production by Mo isolated from nephritic glomeruli (0.14 0.02 U/b3
cells/24 hr) was significantly higher than by blood monocytes (0.03
0.02 U/b3 cells/24 hr, P < 0.05) isolated from the same stage of the
disease. This data demonstrates that TNF is produced by Mo infiltrated
glomeruli and that glomerular Mo have amplified TNF production
compared to their circulating monocyte precursors. This suggests that
Mo may be an important source of gbomerular TNF production. TNF
released by gbomerular Mo may contribute to the mediation of injury in
Mo dependent GN.
Intraglomerular T lymphocyte accumulation in experimental glomeru-
lonephritis in rabbits. M.G. Lowe, P.G. Tipping, S.R. Holdsworth,
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Monash University Department of Medicine, Prince Henry's Hospital,
Melbourne, 3004, Australia. Macrophage (MO) accumulation is prom-
inent in proliferative forms of human and experimental glomerulone-
phritis (GN). Although a role for immunoglobulin Fc-directed MO
accumulation has been shown, recent evidence suggests that cell.
mediated immune (CMI) mechanisms may also direct MO accumulation
and glomerular injury in anti-glomerular basement membrane antibody-
induced (anti-GBM) GN. This mechanism has not been demonstrated in
immune complex-induced (IC) GN. The specific monoclonal anti-rabbit
T lymphocyte antibody LI 1/135 (T.J. Kindt, NIH, Bethesda) was used
to demonstrate T cells within the glomeruli of rabbits with anti-GBM
GN and IC GN by indirect immunofluorescence. Injury in these models
is mediated by MO. T cells were present in the glomeruli of rabbits with
both active anti-GBM GN (1.86 0.58 cells/glomerular cross section
[glom cs]) and IC GN (2.16 1.02 cells/glom cs). The T cell infiltrate
was maximal on day 5 in anti-GBM GN and immediately prior to
immune clearance in IC GN. Peak influx of MO occurred on day 6 and
maximal proteinuria on day 5 in anti-GBM GN (52.8 13.2 MO/glom
and 1826 253 mg/24 hr) and at the time of immune clearance in IC GN
(17.0 8.9 MO/glom and 46 11 mg/24 hr). Intraglomerular T cells
were occasionally observed in some glomeruli in normal rabbits (0.38
0.06 cells/glom cs) and rabbits with a passively induced model of
anti-GBM GN (0.30 0.09 cells/glom cs). These studies show signifi-
cant glomerular T lymphocyte accumulation prior to MO infiltration and
the initiation of glomerular injury in both anti-GBM GN and IC GN in
rabbits. This suggests a potential role of CMI mechanisms in the
pathogenesis of these diseases.
Cyclosporin inhibits angiotensin 11-stimulated mesangial cell prosta-
glandin release. R.J. Walker, V.A. Lazzaro, G.G. Duggin, Royal Prince
Alfred Hospital, Camperdown NSW 2050, Australia. Glomerular
mesangial cells due to their contractile and synthetic properties, play a
major role in regulating intraglomerular hemodynamics. Previous stud-
ies have demonstrated that cyclosporin A (CSA) activates the renin
angiotensin system without an appropriate increase in prostaglandin(PG) release, suggesting this may be a major mechanism in CSA
nephrotoxicity. The aim of this study was to investigate the role of
mesangial cell PG synthesis in mediating CSA nephrotoxicity. Mesan-
gial cells were cultured from cellular outgrowths arising from isolated
glomeruli of Sprague-Dawley rats. Mesangial cells were confirmed on
morphology, immunocytology, and response to physiological stimuli.
Cells were used 8 to 14 days following the first passage. Following a
basal incubation period, cells were incubated with I ml CSA or CSH
(0.02 to 20 sg/ml) or vehicle for 5 mm. 0.5 ml media was aspirated and
replaced with 0.5 ml CSA or CSH plus angiotensin II (All; 108 M, l0-
M) or norepinephrine (NE; l0— M, 10—8 M) and incubated for 5 to 15
mm. Media was aspirated and stored at —80° for PGE2 assay (RIA).
PGE2 is expressed as pg/sg cell protein. Data are mean (sEM) of 3 expts.
NE stimulated PG release was not modified by CSA but All (l0- M)
stimulated PG release (5—15 mm) was significantly (P < 0.01) reduced
by CSA and CSH at all concentrations.
Conc CSA CSA + All CSH CSH + All
Con. 3.48 0.56 6.40 0.55 2.80 0.56 6.04 0.87
0.02 2.24 0.2 5.59 0.87 3.45 0.45 3.72 0.33
0.2 2.50 0.43 4.04 0.42 2.38 0.45 3.73 0.22
2.0 2.77 0.28 4.14 0.84 2.59 0.45 3.27 0.37
20.0 2.25 0.34 3.79 0.39 3.01 0.36 4.44 0.22
Cyclosporine specifically inhibits All receptor-activated PG release
allowing increased mesangial cell contractility in response to increased
All release, and a reduction in glomerular surface area and GFR as seen
clinically.
Use of the fistula assessment monitor to detect stenoses in access
fistulae. J.S. Gani, P.R. Fowler, A.W. Steinberg, R.S. Nanra, A.D.
Hibberd, Hunter Transplant Unit and Department of Nephrology,
Royal Newcastle Hospital, Newcastle, N.S. W. 2300, Australia. Twen-
ty-three randomly selected, maintenance hemodialysis patients with
functioning fistulae were assessed by clinical methods, angiography and
the fistula assessment monitor (FAM). Clinical examination, ease of
cannulation and biochemical parameters of inadequate dialysis together
formed the combined clinical assessment (CCA). Transbrachial fistula
angiography was performed and biplanar radiographs were used to
measure mean diameter + percentage reduction in cross sectional area
(CSA) at stenoses (reduction of 75% was defined as hemodynamically
significant). When compared with angiography, CCA was accurate in
52% of patients [54% sensitivity, 50% specificity (Kc = 0.45, P > 0.2)].
Fistula assessment monitoring was accurate in 96% of patients [100%
sensitivity, 92% specificity (Kc = 0.91, P < 0.01)]. Complications of
angiography occurred in 39% of cases. There were no FAM-related
complications. In predicting clinical outcome at 6 months, 83% of
abnormal FAM fistulae had clotted, required revision or become
clinically unsatisfactory, but 100% of normal FAM fistulae were func-
tioning adequately (accuracy 91%, sensitivity 100%, specificity 83%).
Fistula assessment monitoring was significantly superior to CCA (ac-
curacy 65%, sensitivity 70%, specificity 58%) in predicting outcome at
6 months (P < 0.05). In conclusion, fistula assessment monitoring offers
significant advantages over CCA. It is superior in detecting fistula
stenoses and in predicting clinical outcome at 6 months. Routine FAM
would reduce inappropriate angiography by 25% and would detect
clinically silent, significant stenoses in 27% of patients.
Na, K ATPase inhibitor in end-stage renal failure. G.S. Stokes, L.A.
Norris, iF. Marwood, Hf. Johnston, R.J. Caterson, Hypertension
Unit and Dialysis Service, Royal North Shore Hospital, St. Leonards
NSW2065, Australia. An inhibitor of cell membrane Na, K ATPase has
long been suspected to circulate in uremia. Most evidence cited for its
existence has been indirect, based on changes in cell cation concentra-
tions and transport mechanisms. By measuring effect on Na, P ATPase
activity directly in a linked-enzyme system', we have established the
presence in uremic plasma of a low inhibitor. The table shows %
inhibition (I) SE of Na, K ATPase activity by plasma from normal
control subjects before (N = 15) and during (N = 7) Na depletion or
repletion, from 22 essential (E) hypertensives, from 8 patients with
moderate renal failure (RF), and from 50 patients with end-stage (ES)
RF under these conditions: before a regular hemodialysis (HD), after an
ultrafiltration (UF), after an HD, during CAPD or after in vitro lab
dialysis with 3500 MW membrane.
I(%) l(%)
Control subjects 0.0 0.7 ESRF 7.7 0.9"
Na depletea +0.6 1.4 after UF 74 b
Na repletea +1.9 2.0 after HD 0.5 0.8
E. hypertension —0.8 0.7 lab dialysis 0.9 1.0
Mod. RF —6.3 1.6 during
CAPD
4.1 1.9
° atrial natriuretic peptide concn. normalb P < 0.01
Inhibitor was present in Mod. RF and in ESRF before and after UF. It
was not detected in Na deplete or replete controls, in hypertension, or
in ESRF after HD, CAPD or lab dialysis. We conclude that the inhibitor
is dialyzable but unaffected by volume status. This is not consistent
with the ouabain-like volume regulatory hormone described in some
hypertensive states.'
1. Hamlyn JM, et al: Nature 100:650, 1982
Circadian variability in intraperitoneal (i.p.) IgG concentrations in
continuous ambulatory peritoneal dialysis (CAPD) patients: Lack of
correlation with peritonitis rates. M. Thomas, J. Callaghan, J. Wishaw,
L. Hansen, S. Porter, Renal Unit, Royal Perth Hospital, WA, 6000,
Australia. Recent evidence has suggested an inverse correlation exists
between peritonitis rate and the total IgG concentration in overnight
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dialysate effluent. To determine the relationship between i.p. IgG
concentrations and peritonitis rates, uninfected dialysate effluent sam-
ples were collected over 24 hours on 73 occasions in 38 patients, and
assayed for total IgG using double antibody ELISA. I.p. IgG results
(mcg/ml) were expressed as the daily maximum (max), minimum (mm),
mean and within-day variability (= [max-min]/mean x 100) per pa-
tients. Concurrent serum immunoglobulin concentrations were deter-
mined by nephelometry. Peritonitis (dialysate WCC> 100/mI & posi-
tive culture) frequency was expressed in episodes per month of
treatment. Correlation was performed with the Spearman or Pearson
coefficient where appropriate. Marked circadian variation was found
with i.p. IgG daily max = 187 125 (SD), mm = 33 47 and mean =
100 92 mcg/ml; variability was 196 108%. Total serum IgG was 10.0
4.5 g/liter, hypogammaglobulinemia was found in 7 (18%) of patients.
Peritonitis rate was 0.14 0.07 episodes/month. No correlation was
found between peritonitis rates and either serum or i.p. EgG concentra-
tions, whether expressed as max, mm, mean or variability. Serum IgG
correlated with i.p. IgG max (P < .0005), mm (P < 0.0001) and mean (P
< .01), but not variability. This study has demonstrated that IgG is
present in CAPD effluent at 1% of serum concentration, with wide
between-bag variation. Factors other than host i.p. IgG concentration
appear to contribute to susceptibility to peritonitis.
Characterization of a novel T-cell lymphokine and predicted structural
homology. M.C. Falk, H. Kim, T.J. Schall, C. Clayberger, A.M.
Krensky, Department of Paediatric Nephrology, Standford University,
Stanford, Ca 94305, USA. T lymphocytes regulate the immune re-
sponse in part through a group of small secreted proteins called
lymphokines. Using a cDNA library enriched for human cell specific
sequences, we have identified a T cell specific gene called RANTES,
which encodes a small secreted molecule. The RANTES gene product
is predicted to be 10 kD and after cleavage of the signal peptide, the
mature protein is about 8 kD. There are 4 cysteines out of a total of 68
amino acid with no sites for N-linked glycosylation. RANTES is
expressed by CD4+ and CD8+ T cell lines which are antigen specific
and growth factor dependent. Expression is inducable in peripheral
blood lymphocytes. Using RNAse protection assays, RANTES was
found to be constitutively expressed in activated T cell lines. Expres-
sion was maximum in antigen or mitogen stimulated peripheral blood
lymphocytes 5 to 7 days after activation. Interestingly, no human T cell
tumors expressed RANTES. Analysis of predicted structural homology
in particular those involving the cysteine residue spacing suggests that
the molecule encoded for by RANTES is part of a family of small T cell
secreted factors by platelets, macrophages, neutrophils and lympho-
cytes. Characterization of the physiological role of these molecules may
allow the design of new diagnostic and/or therapeutic modalities for
disease states involving activated lymphocytes.
OKT3 in steroid-resistant renal transplant rejection. A.C. Restifo,
J.J.B. Petrie, R.J. Rigby, I.R. Hardie, J.R. Burke, P.G. Row, R.W.
Strong, D.R. Wall, S.V. Lynch, J.M. Quinn, P.W.H. Woodruff, Renal
Transplant Unit, Princess Alexandra Hospital, Brisbane, Queensland,
Australia. Forty-six courses of OKT3 were given to 37 renal allograft
recipients: 29 first grafts and 8 subsequent grafts. All were on cyclos-
porine (CsA) with 30 on triple therapy; 8 had also had ATOAM for
rejection or initial non-function (INF). Four courses of OKT3 were
given for INF, I for hyperacute rejection (HR) and 41 for episodes of
acute rejection (AR), of which 38 were steroid resistant and 35 were
biopsy-proven. CsA was ceased when OKT3 was given but azathio-
prine was continued. Of the 41 episodes of AR treated, 7 were
re-treatments from which 1 graft was lost. Biopsies were not done with
6 episodes; all of these responded to treatment but I patient died due to
encephalitis. Of the 35 biopsied episodes, 15 were due to pure cellular
rejection (CR); all 15 responded to treatment and although rejection
recurred in 6, only 1 graft was eventually lost with superimposed
vascular rejection (VR). In the 20 episodes where VR was present 16
responded, rejection recurred in 8; 7 grafts were lost due to rejection
and 2 patients died (I myocardial infarction, I CMV infection). The
difference in graft losses due to VR compared with CR was significant
(P < 0.025). In all, 10 grafts were lost: 7 with VR, I with HR and 2
deaths with grafts in situ. There were 56 infections in 78% of all patients
treated: 23 bacterial, 31 viral (65% herpes simplex), 1 pneumocystis
carinii and 1 giardiasis. Most infections were not serious but there were
2 deaths from viral infection. OKT3 reverses biopsy-proven, steroid
resistant CR. VR may also respond but it has a poorer prognosis.
Infections, particularly viral infections, are frequent.
Experimental diabetic nephropathy: The role of genetic hypertension
and antihypertensive therapy. P.A. Macmillan, M.E. Cooper, T.J.
Allen, R.C. O'Brien, G. Jerums, A.E. Doyle, Endocrine Unit, Austin
Hospital, Heidelberg, 3084, Australia. To evaluate the role of hyper-
tension in the evolution of experimental diabetic nephropathy, we have
combined genetic hypertension with diabetes by inducing streptozo-
tocin (STZ) diabetes in the spontaneously hypertensive rat (SHR).
Controls included non-diabetic SHR and normotensive [Wistar Kyoto]
(WKY) diabetic rats. A separate group of diabetic SHR were treated
from induction of diabetes with either enalapril [ENAL] (35 mg/liter) or
a combination of hydralazine (50 mg/liter) and metoprolol (50 mg/liter)
[HM] in drinking water. Animals were followed for 32 weeks with
monthly estimations of weight, systolic blood pressure (SBP), glycemic
control, renal function and urinary albumin excretion (UAE) before
sacrifice for assessment of glomerular basement membrane thickness
(GBMT), mesangial expansion (MES) and glomerular volume (GV) by
quantitative histomorphometry. Data at 32 weeks are shown (Table,










WKY 7 136 2 0.9 140 2 9.1 0.6 590 39
Diabetic 11 135 2 3.5 161 4 13.0 0.8 671 33
WKY
SHR 8 213 3 31.7 154 5 12.3 0.8 1009 68
Diabetic 11 200 3 65.2 183 4 14.8 0.9 926 65
SHR
Diabetic SHR had increased albuminuria, GBMT and GV when com-
pared to diabetic WKY. Diabetic animals had increased albuminuria,
GBMT and MES when compared to their appropriate non-diabetic
controls. In diabetic SHR, both drug regimens were equivalent in
hypotensive efficacy (ENAL 148 5, N = 11, vs. HM 155 4mm Hg,N = 10, both P < 0.01 vs. diabetic SHR) as well as in reduction of
albuminuria (ENAL 17.6 1.3, HM 23.3 1.3 mg/24 hrs, ENAL vs.
diabetic SHR, P < 0.01; HM vs. diabetic SHR, P < 0.05; ENAL vs.
HM, NS) and GBMT (ENAL 160 5, HM 161 8 nm, ENAL vs.
diabetic SHR, P < 0.01; HM vs. diabetic SHR, P < 0.01; ENAL vs.
HM, NS) without influencing MES (ENAL 16.2 1.2, HM 15.6
0.9%) orGY (ENAL 965 102, HM 844 41 sm3 x l0). The diabetic
SHR has features of accelerated nephropathy. Both antihypertensive
therapies had similar effects on albuminuria and glomerular ultrastruc-
ture.
Chronic angiogensin converting enzyme (ACE) inhibition in Goidblatt
hypertension leads to irreversible renal atrophy in the rat. B. Jackson, L.
Franze, E. Sumithran, C.!. Johnston, University of Melbourne Depart-
ment of Medicine, Austin Hospital, Heidelberg, and Division of Labo-
ratory Medicine, Monash Medical Central, Clayton, Victoria, Austra-
lia. To evaluate the long-term effects of angiotensin converting enzyme
inhibitor treatment in renovascular hypertension we have treated rats
with the 2 kidney-l clip model of hypertension with enalapril (E, N =
25) and compared results with minoxidil (M, N = 33) or no treatment
(NT, N = 37). After 12 months of treatment survival was 84% (E), 48%
(M), and 15% (NT). Kidney function (51 CrEDTA clearance mllmin) in
the stenosed kidney of survivors at 12 months was 0.0 (E), 0.26 0.23
(M), and 0.74 0.13 (NT). Function did not return in the stenosed
kidney 2 weeks following withdrawal of E (N = 5). Histological
examination revealed marked interstitial fibrosis and tubular atrophy in
the clipped kidneys from the E group, in contrast to minor changes in
the M and NT groups. Chronic ACE inhibitor treatment may lead to
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irreversible fibrotic atrophy of the clipped kidney in 2 kidney-I clip
Goldblatt hypertension.
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Renal failure due to cholesterol emboli. 1. Fraser, B. Ihie, P. Kincaid-
Smith, Department of Nephrology, Royal Melbourne Hospital, Victo-
ria, 3050, Australia. Renal cholesterol embolization may lead to irre-
versible renal failure. Early reports were usually associated with a fatal
outcome. With the increased use of angiographic procedures this
condition may well be more frequent than is currently being diagnosed.
Definitive diagnosis requires demonstration of cholesterol emboli by
fundoscopy or biopsy. We report 8 patients who presented over a 9 year
period with renal failure. All patients were males aged 59 to 73 years.
Five cases related to angiographic studies, 2 cases following motor
vehicle accident and one after aorto-iliac aneurysm repair. The time
that elapsed from insult until presentation varied from 0 day to 42 days( 14.6 days). The peak creatinine concentration ranged from 0.27 —
1.20 mmollliter. The diagnosis was made by renal biopsy in 6 cases and
at autopsy in 2. Four patients survived the initial event, 2 patients are
on chronic HD, I had a short course of HD and recovered and 1
remained stable for 2 years with imparied renal function. A recent
review showed that only 5% of patients survived. Acute renal failure in
elderly patients post-vascular surgery, angiography or severe trauma
requires a high index of suspicion and early histological confirmation for
optimal management.
Parathyroidectomy (PTHTX): Subtotal (ST) versus total with auto-
transplantation (T&AT). B. Ihie, J.H. Zhang, G. Becker, G. Clunie, P.
Kincaid-Smith, Departments of Nephrology and Surgery, Royal Mel-
bourne Hospital, Victoria 3050, Australia. Controversy exists on the
relative value of ST versus T&AT in PTHTX. We evaluated the results
of our PTHTX over a six-year period. All patients were studied with
regard to perioperative needs of Ca replacement, improvement in
symptoms, biochemistry, x-ray changes. All patients had a minimum of
12 months follow-up. A total of 58 operations were performed in 55
patients (42 ST and 16 T&AT). There were 25 M & 30 F with age of
38.45 14.9 (12 to 70 yrs). Nine patients were pre-end-stage CRF.
Fourteen were on long-term chronic HD ( 2.3 2.1 yrs). Twenty-
seven patients were on chronic HD following a failed transplant ( 2.8
2.4 yrs). Four patients had a PTHTX with functioning graft. Indica-
tions for PTHTX were: bone pain 49%; pruritus 33%. The majority,
however, had severe biochemical disturbances despite good medical
therapy. Ninety-eight percent had severe x-ray changes and bone
biopsy was consistent with osteitis fibrosis in 97%. The i follow-up was
42 months in ST and 31 months in T&AT. The no. of days for i.v. Ca
supplements and the nadir was no different between the two groups: 4.6
days and 1.7 mmol/liter respectively. Symptoms had disappeared in 1
month in >60% of patients in both groups. PTH levels were normal in
60% at 10 months and AP was normal within 6 months in >85%. X-ray
improvement was >70% in both groups at the end of follow-up period.
Conclusion: Except for ease of re-operation with recurrence of HPTH
there is no difference in the immediate or long-term results between ST
versus T&AT PTHTX.
Characteristics of proximal tubular epithelium and fluid during trans-
fer between non-expanded and volume expanded rats. S. Reddy, C.C.
Cochineas, A.Z. Györy, Departments of Medicine, University Sydney
and Renal Medicine at The Royal North Shore Hospital, St. Leonards,
2065, Australia. Volume expansion is known to inhibit proximal tubular
Na transport. We have previously shown that, during both mannitol
saline and saline volume expansion (SVE) inhibition of both volume
flux (J1) and Na transport (transepithelial Na concentration difference)
was dependent on the type of tubular fluid (TF) used: whether artificial
(AS, 0—20%) or harvested autologous fluid (HTF, 40-50% inhibition).
Using the shrinking drop technique (evaluator blinded, precis ion 6%),
we measured J,1 in non-expanded (recipient) rats with AS alternating
with either HTF or with harvested proximal tubular fluid from donor
rats (HTFD) which had undergone SVE, and vice versa. Results in
diagram show that both TF and epithelium were altered during SVE.
The Na transport inhibiting factor which appears following SVE is also
transferable resulting in proximal tubular transport inhibition in non-
expanded rats. In addition proximal epithelium is also altered such that
Na transport is inhibited when in contact with native unaltered fluid. A
humoral interaction best explains these results.
Metabolism of C4 gene products in lupus nephrltis. B.A. Pussell, P.
Peake, V. Timmermans, L. Gavrilovic, J.A. Charlesworth, Department
of Nephrology, Prince Henry Hospital, Little Bay, NSW, 2036, Aus-
tralia. The fourth component of complement is controlled by a tandem
gene with 2 loci: C4A and C4B. Functional differences in C4 products
of these loci have been described in vitro and include differences in
hemolytic activity (C4A greater than C4B) and surface interaction with
immune aggregates (C4B greater than C4A). The specific aim of this
project was to identify in vivo metabolic differences between isotypes
of the A and B genetic loci by studying the metabolism of two purified
C4 proteins, C4A3,Bl and C4A3,B0, simultaneously in five control
subjects and six patients with active immune complex disease. The
fractional catabolic rate (FCR) of 1311.C4A3,Bl was significantly greater
than that of '251.C4A3,B0 in patients (3.98 1.37 vs. 3.31 0.85%/hr;
mean SD, P < 0.05) but not in control subjects. Three patients with
SLE showed a non-linear pattern of plasma disappearance of radioac-
tivity and two of these had homozygous C4A deficiency. Calculated
values for FCR of the B locus isotype were significantly greater than
those for the A locus (4.67 0.96 vs. 3.31 0.85%/hr; P < 0.05) in
patients but not in controls. Extravascular distribution ofC4A3,Bl was
greater than that of C4A3,B0 in all subjects and values in patients were
higher than in controls. Null alleles in patients and controls did not
influence rate of turnover of injected proteins. The data show that
turnover of C3B-derived proteins is greater than those produced by the
C4A locus in patients with pathological complement activation. Such a
finding supports the functional differences between isotypes that have
been demonstsrated in vitro and provides evidence for tissue activation
of complement in excess of plasma activation. The frequently observed
deficiency of C4A in SLE indicates that such patients have a defect in
handling circulating immune complexes but retain functional comple-
ment integrity at the tissue level.
The expression of gamma-interferon in rat renal allografts. PG. Kerr,
V.C. Marshall, R.C. Atkins, Departments of Nephrology and Surgery,
Prince Henry's Hospital, Melbourne 3004, Australia. Renal allograft
rejection is associated with marked leucocytic infiltration into the
rejecting tissue. There is considerable dispute at to the relative roles
played by CD4 and CD8" lymphocytes in this process; certainly
there is evidence for both cell types operating in rejection. By using
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immunoperoxidase techniques we have examined this problem in terms
of the particular leucocytes involved with particular attention to the
activation status of those leucocytes present. Further by examining the
evolution of the allograft infiltrate the developing pattern of rejection
has been examined. DA (RTl) and AS (RTI') kidney transplants were
performed and the unimmunosuppressed kidneys harvested on days 1,
2, 3, 4 and 5 post-transplantation. Immunohistology on PLP-fixed tissue
using a 3-layer peroxidase technique was performed with a broad range
of anti-rat monoclonal antibodies including ART-l8 (IL-2R), OX 6
(Class II), Al-3 macrophage pro-coagulation activity), and DB-1 (Gam-
ma-IFN). The infiltrate density approximately doubled daily from days
1 to 4 (74 3 total leucocytes/0.2 mm2 day I vs. 1011 27 total
leucocytes/0.2 mm2 day 4) and increased further only a minor degree on
day 5 (1097 107 total leucocytes/0.2 mm2). CD4 cells predomi-
nated up until day 3 (CD4:CD8 ratio day 5 — 0.53). Gamma-IFN was
positive in T cells on day 2 (73% of all T cells) and slightly on day 3 (5%
of all T cells) but was absent on days 4 and 5 (and reappeared on days
6 and 7). Activation markers such as IL-2R, Ia induction and macro-
phage pro-coagulant activity appeared after the surge of gamma-IFN.
These results heavily favor the CD4e cell as being pivotal in trans-
plant rejection; these lymphocytes releasing lymphokines early in the
rejection process and recruiting CD8 cells.
Deoxyspergualin: An anti-monocyte immunosuppressant? P.G. Kerr,
R.C. Atkins, Department of Nephrology, Prince Henry's Hospital,
Melbourne 3004, Australia. 15-Deoxyspergualin (DOSP) is a new
immunosuppressant drug. It has been shown to be immunosuppressive
in rats and dogs in several organ transplants. Some have claimed that
DOSP has a predominantly anti-macrophage effect. In human lympho-
cyte mitogen proliferation assays we found that DOSP inhibits signifi-
cantly, in a dose dependent fashion, the PHA, ConA and PWM assays
(e.g. ConA response: inhibited to 66%, 25% and 16% of control values
at doses of 1, 10 and 100 g/ml DOSP, respectively) except that it
stimulates the PHA response at 1 pg/mi (in 2 of 3 experiments, P = NS).
The response of the MLR to DOSP was also examined. Using normal
human peripheral blood mononuclear cells versus Raji cells we found
that, similar to the PHA response, the MLR was also inhibited in a dose
dependent fashion by DOSP (inhibited to 53% of control at 10 tg/ml and
36% at 100 g/ml) except at low doses when it also was stimulated (133
74% of control at 1 g/ml). When the monocytes alone were treated
with DOSP, the MLR was again significantly inhibited; thus suggesting
that DOSP does have an anti-monocyte effect. Similarly the mitogen
proliferation results do not detract from this hypothesis as they are well
known to be monocyte dependent. We have also examined the immu-
nohistology of rat renal allografts treated with DOSP for up to 10 days.
Using a DA (RTI) to AS (RT1') model of rat renal allograft rejection
we used a dose of 2.5 mg/kg of DOSP. Immunohistology of engrafted
kidneys harvested at 5 and 10 days revealed a moderate interstitial
infiltrate comprising approximately 40:60 lymphocytes:macrophages
but expressing only a low percentage of activation markers (e.g.
IL2R+e cells: 12% of total leucocytes in DOSP treated kidneys vs.
25% of total leucocytes in day 5 unimmunosuppressed kidney). Unim-
munosuppressed controls are "destroyed" by days 7—8. Thus DOSP,
like cyclosporine, is associated with a modified leucocytic infiltrate in
transplanted kidneys.
Renal epithelial cell response to retinoic acid. A. Argiles, N. Kraft, P.
Hutchinson, S. Senes-Ferrari, R.C. Atkins, Department of Nephrol-
ogy, Prince Henry's Hospital, Melbourne 3004, Australia. Recent
evidence suggests that retinoic acid (RA) is involved in compensatory
kidney growth, along with other retinoids. Retinoids have been de-
scribed as growth factors for a variety of cell types but their effects on
renal cells are relatively unknown. We have studied the effects of RA on
a rabbit epithelial cell line, RKI3, as epithelial cells form a major part of
the kidney and are recognized as the major cell type involved in
compensatory growth. RA caused an increase in 3H-thymidine uptake
within 6 hours (P < 0.05, Student's t-test) and this effect was main-
tained for 5 days. At 24 hours the mean increase for 6 experiments was
42 8% (P < 0.01). The thymidine incorporation analysis was
confirmed by flow cytometric determinations of cellular DNA content.
RA decreased the cell numbers in G0-Gl phase by 9.4 2% (P < 0.01),
indicating that an increased proportion of cells were entering cell
division. In addition, measurements of total cell protein were performed
and RA caused an increase of 37 4% (P < 0.01, Day 1). Similar results
were obtained for cells growing in RPM! 1640 in the presence or
absence of 10% FCS. We conclude that the RA induced changes were
compatible with those observed in cells undergoing compensatory
kidney growth. These changes were not due to the potentiation of
serum growth factors as they were also seen in cells grown for 3 days in
serum-free medium. As the same results were obtained in confluent and
non-confluent cultures, we conclude that RA activity is not due to the
modification of the contact inhibition phenomenon.
Interleukin-2 inhibits mesangial cell proliferation. Y. Kakizaki, N.
Kraft, R.C. Atkins, Department of Nephrology, Prince Henry's Hos-
pital, Melbourne 3004, Australia. Hypercellularity of the glomerular
mesangium is present in various forms of glomerulonephritis. Recent
reports have demonstrated that the growth of mesangial cells (MC) may
be affected by several factors, including interleukin 1. We have discov-
ered an inhibitory effect of interleukin 2 (LL-2) on the proliferation of rat
MC in culture and the existence of !L-2 binding sites on MC. The effect
of IL-2 on MC growth was determined in four different culture
conditions by the measurement of 3H-thymidine incorporation 2, 4 and
6 days after exposure to IL-2. In 20% FCS (a), a distinct inhibitory
effect of IL-2 was observed at 5 and 20 U/mI in a dose-dependent
manner. In 5% FCS (b), a similar effect was observed and 1 U/mI IL-2
significantly suppressed thymidine uptake. IL-2 also inhibited the
proliferation following release from growth-arrest in logarithmic growth
phase (c) and in confluency (d). Percent control values at 20 U/mI on
day 4 were 51, 53, 39 and 34% in (a) through (d), respectively.
Epidermal growth factor (1 to 100 ng/ml), however, markedly increased
thymidine uptake in MC. The absorption of !L-2 by MC was demon-
strated by using a thymocyte proliferation assay. Following incubation
with MC, 34 to 64% of the biological activity of IL-2 was lost. A
radioimmunoassay for !L-2 receptor on MC using the !L-2 receptor
monoclonal antibody (ART-18) showed that these receptors were
present in three experiments. These experiments suggest that !L-2 may
play an important role in MC proliferation, presumably via the interac-
tion with a specific cell-surface receptor, and that activated T lympho-
cytes may participate in the regulation of MC proliferation.
IgA fibronectin (FN) collagen-binding complexes in IgA nephropathy(IgA GN). M. Thomas, P. Hollingsworth, S. Mallal, B. Saker, R.
Dawkins, Departments of Clinical Immunology & Renal Medicine,
Royal Perth Hospital, Perth, WA, 6000, Australia. The antigen in the
circulating immune complexes in IgA GN remains unspecified. Sera
from some IgA Gn patients can bind to the FN-binding fractions of
intact and denatured collagens I, II & IV, and plasma FN contains
collagen-binding domains. Serum !gA FN complexes (<1% of total
IgA) binding to collagen have recently been demonstrated in !gA GN
patients. To determine the specificity of this observation, stored serum
from patients with mesangial proliferative GN with (N = 24)or without(N = 14) !gA deposition, patients with high serum IgA without ON (N
= 5), patients with rheumatoid factor or antinuclear antibodies (N = 3)
and normal subjects (N = 2) were assayed for IgA FN collagen-binding
complexes by ELISA (kit courtesy of Dr. B. Cederholm, Sweden).
Results were expressed as median (m) and ranges (r) of optical densities
(OD); normal range < 3 x OD of negative control; marked elevation =
OD > 0.40. !gA ON patient's sera showed a bimodal distribution with
11 patients showing normal-moderate OD elevation (m = 0.10, r = 0.02
to 0.25) and 13 patients showing marked OD elevations (m = 0.47, r =
0.40 to 0.65). Patients with nonlgA ON had only normal-moderate OD
elevations (m = 0.11, r 0.01 to 0.23). Patients with high serum !gA
concentrations showed mild-marked OD elevation, (m = 0.28, r = 0.12
to 0.60). Patients with autoantibodies did not differ from normal
subjects. Elevations in serum !gA FN complexes binding to collagen
are not specific to !gA nephropathy; mild-moderate elevations are
found in other nonlgA proliferative ON. Marked elevations in concen-
trations of this complex were limited to !gA GN in all but one sample.
Correlations with clinical features of !gA GN are in progress.
Bull-terrier nephropathy: A model of Alport's syndrome? J. Hood, C.
Huxtable, W. Robinson, W. Clarke, R. Sutherland, S. Shaw, M.
Thomas, School of Veterinary Studies, Murdoch University, and Renal
Unit, Royal Perth Hospital, WA, 6000, Australia. Familial renal disease
has been described in several breeds of dog, To determine the preva-
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lence, and clinical and pathologic features of a recently observed
nephropathy among bull terriers (BTs), 4 groups of dogs were studied:
i) azotaemic (s. creatinine > 500 mol/liter) BTs, (N = 10, aged 1 to 6
yrs, 8 males); ii) proteinuric (urine protein/creatinine > 0.3) non-
azotaemic BTs, (N 14, aged 2 to 10 yrs, 8 males); iii) nonproteinuric
BTs (N = 8, aged ito 7, 4 males); and iv) normal non-BTs (N = 11,
aged Ito 7 yrs, 7 males). Azotemic BTs had elevated serum phosphate,
cholesterol and glucose; gross and microscopic changes in the kidney
showed end-stage renal disease. Proteinunc BTs had low serum albu-
min and elevated cholesterol without peripheral oedema. Hematuria
was detected by urinalysis in 3 azotemic, 11 proteinuric and 5 nonpro-
teinuric BTs, and 7 normal nonBTs. Light and electron microscopic
examination of ultrasound-guided renal biopsies in proteinuric (N = 4)
and nonproteinuric (N = 2) BTs, compared to normal non-BTs,
revealed predominantly glomerular basement membrane abnormalities
of thickening and splitting, similar to human Alport's syndrome and
hereditary nephritis in Samoyed dogs. Pedigree analysis revealed all the
probands to be related and nearly all to share a common ancestor, the
affected male: female ratio was 2.1 and the prevalence of asymptomatic
proteinuria in the local BT population was 43%, all suggesting an
inherited and possibly X-linked strongly penetrant disease. This breed
is known for deafness. Further studies of appropriate sire and dam
matings, glomerular immunohistology, quantitative audiometry, and
kindred DNA analysis are in progress.
Hyperparathyroidism (HPTH) and vitamin P metabolic abnormalities
in mild-moderate chronic renal failure. M. Thomas, A. St. John, C.
Davies, B. Mullan, B. Hutchison, A. Van der Schaaf, I. Dick, R.
Prince. Departments of Renal Medicine, Biochemistry & Nuclear
Medicine, Royal Perth Hospital, and Departments of Medicine, Nu-
clear Medicine & Renal Medicine, Sir Charles Gairdner Hospital,
Perth, WA, 6009, Australia. Development of a new immunochemilumi-
nometric assay for intact parathyroid hormone (PTH)' has prompted
re-examination of the level of renal impairment at which calcitriol
(1 ,25D) deficiency, HPTH and altered renal phosphate handling are first
detectable. Twenty stable outpatients with glomerular filtration rates
(GFR,TCm DTPA) 30 to 90 mI/mm and not receiving steroids, Vit D,
calcium or phosphate binding medication, were studied. Serum dialys-
able calcium, intact PTH, alkaline phosphatase, & l,25D (bovine
thymus cytoreceptor assay), serum and urine calcium, phosphate &
creatinine, and fasting urinary cyclic AMP (UcAMP) were assayed.
Elevated intact PTH concentrations were found in 12 of 15 patients with
GFR <60 mIs/mm and in 1 of 5 with GFR >60, whereas reduced l,25D
concentrations were found at a GFR < 80 in 15 of 18 patients and in 0
of 2 with GFR > 80. When corrected for GFR, I ,25D concentrations
were normal or raised and correlated with intact PTH and markers of
HPTH (raised UcAMP, lowered phosphate threshold and calcium
excretion). Serum phosphate, ionised calcium and alkaline phosphatase
concentrations were all within normal limits. This study has confirmed
and extended our findings in moderate chronic renal failure2 that
impaired I ,25D production is a major feature of mild to moderate
chronic renal failure (GFR 30 to 80 mI/mm), and possibly antedates, and
is partially corrected by, serologically detectable hyperparathyroidism.I. J Clin Endocrin Metab 65:407, 1987
2. Kidneymt 33:722, 1988
Antineutrophil cytoplasm antibody (ANCA): Large scale serological
screening and long-term follow-up of ANCA associated vasculitis. Al.
MacIsaac, J.E. Moran, D.J. Davies, B.F. Murphy, T. Georgiou, J.F.
Niall, Renal Unit and Department of Anatomical Pathology, St Vin-
cent's Hospital, Fitzroy 3065, Victoria, Australia, Antineutrophil cyto-
plasm antibody (ANCA) was first described in 1982. From 1977 7,500
sera were screened for ANCA. ANCA was not detected in any patient
without vasculitis. Ninety-eight patients with vasculitis were ANCA
negative, including 7 with microscopic polyarteritis nodosa (MPAN)
and 8 with Wegeners granulomatosis (WG). Fifteen patients presenting
with this antibody were followed for an average of 5.8 yrs (range 0.3 to
9.5 yrs). Eight were males and 7 females. Average age was 57.8 years.
Eleven patients had MPAN, 3 WG and I a cutaneous vasculitis.
Remissions were obtained with immunosuppresion in all patients 0.5
episodes of clinical relapse occurred. ANCA was 100% sensitive in
detecting relapses and 50% specific. Forty-seven percent of patients
presented with a serum creatinine >0.2 mmol/liter and 26% initially
required dialysis. Five year dialysis-free survival was 86%. Mortality
was 20% with a 5 year survival of 91%. This data shows that ANCA is
a specific marker for a sub-group of patients with vasculitis and is a
sensitive marker of disease activity. ANCA positive vasculitis has a
favorable clinical outcome with immunosuppressive therapy.
Altered blood rheology as a contributing factor to the pathogenesis of
glomerulopathies. B.!. Shand, R.R. Bailey, K.L. Lynn, R.A. Robson,
Department of Nephrology, Christchurch Hospital, Christchurch, New
Zealand. Blood flow through vessels is determined primarily by the size
of the vessel and secondly by the viscosity of the blood and the driving
pressure. Glomerular blood flow may be especially susceptible to
changes in blood viscosity (rheology) because of the structure of the
renal microvasculature and as a result of hemoconcentration caused by
ultrafiltration. Because the postglomerular vessels are narrower, in-
creases in blood viscosity may impair glomerular function by causing a
proportionately greater increase in resistance to flow in these vessels.
This sequence of events would result in raised intraglomerular pressure
and glomerular hyperfiltration, regarded as the forerunner of compen-
satory and later pathological changes. We evaluated the possible role of
changes in blood rheology in the pathogenesis of IgA nephropathy and
diabetic nephropathy. Preliminary findings of a two-year longitudinal
study show significantly different rheological indices in both diabetic (N
= 72) and IgA nephropathy (N = 42) patients. While the abnormal
findings were qualitatively similar in both patient groups, the diabetic
patients were characterized by a greater change in plasma viscosity and
red blood cell (RBC) aggregation. In contrast, patients with IgA
nephropathy had more severely impaired RBC deformability, an impor-
tant property of the cell that permits it to pass through the microvas-
culature. The rheological abnormalities were greater in patients with
overt diabetic nephropathy or long-standing IgA nephropathy. These
findings suggest that while change in blood rheology may be involved in
the early pathogenesis of glomerulopathies, the viscosity-induced im-
pairment in renal blood flow may become more manifest in the later
phase of the disorders.
Alteration in charge of plasma IgA in acute Henoch-sehonlein purpura
(HSP). J.F. Knight, P. Hobby, C. Chantler, D.G. Williams, Renal Unit,
UMDS, Guy's Hospital, London, United Kingdom. The charge distri-
bution of circulating IgA in 20 acute and II convalescent plasma
samples from 20 children with HSP was examined by isoelectric
focusing. Gels were immunofixed with polyclonal goat anti-human IgA,
washed with 0.9% saline and then stained with Coomassie blue. The
bulk of the IgA in all samples tested focused at p14.3 to 5.4. In 19 of 20
(95%) acute and 7 of 11(64%) convalescent HSP plasma samples an IgA
band at p1 5.92 was also clearly identified. This band was discernible at
a lower density in 5 of 12 (41%) samples from unaffected children,
which was significantly less than the frequency seen in acute HSP (P <
0.01 x2). Distribution of IgA at different isoelectric points was quantified
by saline elution of 3 mm segments of the gel. The IgA eluted at p1 5.92
was shown to be polymeric by immunoassay of HPLC fractions:
molecular wt was approximately 400 kD. ,, y and Fca were detected in
the p1 5.92 eluate by Ouchterlony immunodiffusion. Acute HSP is
associated with an alteration in the charge distribution of plasma IgA.
Lead (Pb) chelation in an anuric patient. S.D. Roger, D.C.H. Harris,
Renal Laboratory, Westmead Hospital, Westmead NSW 2145, Austra-
lia. The successful treatment of Pb intoxication with intravenous
ethylene-diamine-tetra-acetic acid (EDTA) depends on urinary excre-
tion of chelated Pb. This route of excretion was not available in a
48-year-old patient with childhood Pb exposure, end-stage renal failure,
encephalopathy and severe myeloradiculopathy. Diagnosis was con-
firmed by a positive lead chelation test CaEDTA lg IV!, (urinary Pb
excretion: control 0.04 smolIday, peak 2.96 mol/day), and neurophys-
iological studies. With the initiation of CAPD and the administration of
EDTA the patient became anuric, precluding standard chelation ther-
apy. Baseline daily peritoneal excretion of Pb was <0.08 jnnol.
Following Ca-EDTA Ig lvi peak daily peritoneal Pb excretion was 3.34
mol (day 2), and total 4 day peritoneal Pb excretion 9.29 mol, a
similar value to the mean 4-day urinary Pb excretion reported for
patients with chronic renal failure and lead exposure. Following intra-
peritoneal Ca-EDTA (1 g in overnight bag) peak daily peritoneal Pb
excretion was 2.1 mol and total 4-day peritoneal Pb excretion 6.3
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smol. With both routes of administration of EDTA excess lead excre-
tion persisted for 6 days. The patient continues intraperitoneal chelation
therapy at home. In conclusion: (1) peritoneal removal of chelated Pb is
as effective as urinary excretion; and (2) peritoneal administration of
EDTA is almost as efficient as intravenous EDTA in removing Pb, and
allows home chelation therapy.
Parathyoidectomy (PTHX) in chronic renal failure (CRF): A review of
20 patients. R. De Leon, M. Epstein, J. Gillies, R.G. Evans, R.S.
Nanra, Departments of Nep/zrology, Endocrinology and Surgery,
Royal Newcastle Hospital, Newcastle, N.S. W. 2300, Australia. Eight
non-dialyzed patients with CRF (mean serum creatinine 0.55 SD 0.27
mmollliter), 11 on maintenance dialysis (mean 38.6 SD 27.5 months) and
1 post-transplant (41 months) had PTHX for progressive renal osteo-
dystrophy; the mean age of the patients was 50.1 SD 12.8 years. The
major preoperative features were: hypercalcemia, 2.97 SD 0.18 mmol/
liter; elevated serum alkaline phosphatase (SAP) 163 to 2014 tzlliter;
high serum intact PTH, 758 SD 325 pg/mI; radiological hyperparathy-
roidism (HP) (13 of 20 patients); and, bone biopsy changes of predom-
inant HP (13 of 18 patients) and predominant osteomalacia (5 of 18
patients). Nineteen of 20 patients were prepared for surgery with high
dose calcitriol, 0.5 to 2.0 meg/day for 10 to 14 days preoperatively.
Subtotal PTHX were performed with removal of 1.4 to 12.6 g parathy-
roid tissue. Immediate postoperative symptomatic hypocalcemia (mean
1.99 SD 0.33 mmol/liter) developed in 8 of 20 patients; fits, cardiac
arrythmias, pulmonary edema or immediate mortality were not noted
and no patient with CRF required immediate maintenance dialysis. The
mean hospital stay of patients was 9.2 SD 4.0 days. Eighteen of 20
patients were significantly improved; the long-term serum calcium was
2.47 SD 0.26 mmol/liter, SAP 147 SD 119 Mlliter, and intact PTH 151 SD
202 pg/mI. Recurrent HP developed in 2 patients within 24 months.
Conclusion: PTHX following preoperative calcitriol is a safe and
effective form of treatment in selected patients with progressive renal
osteodystrophy.
Hypoxic acute renal failure: Cation gradients and energetics studied
using DNa, Rb and 31P nuclear magnetic resonance (NMR). Z.H.
Endre, J.L. Allis, G.K. Radda, Department of Medicine, University of
Queensland, Australia, and Department of Biochemistry, University of
Oxford, United Kingdom. Mammalian cell sensitivity to hypoxia may
arise from high membrane permeability combined with ATP depletion
causing rapid loss of ionic gradients.' 23Na, 87Rb (as a K congener) and
were used to study hypoxia-induced changes in intact kidney. Right
kidneys from Wistar rats were perfused at 37°C with recirculating Krebs
bicarbonate buffer containing 6.7 g% bovine serum albumin, 20 amino
acids and 5 m glucose, and gassed with 95% 02, 5% Co2. Kidneys
were perfused within an "earphone" coil triple tuned to 23Na (48.3
MHz), 87Rb (59.9 MHz) and 31P (73.8 MHz) allowing spectra to be
acquired sequentially with a respective time resolution of 30 see, 4 mm
and 4 mm. After 30 to 45 mm baseline perfusion, RbCl was added to 1.5
mM and uptake monitored to steady state (approximately 40 mm).
Hypoxia was then induced by switching the gas mixture to 95% N2, 5%
CO2. The onset of hypoxia was followed immediately by an increase in
total renal Na and decreases in Rb and ATP. The rate constants for
whole kidney were: 87Rb decrease (0.16 0.07 min', SD, N = 3),
23Na increase (0.30 min, intracellular Na, N = 2) and ATP decrease
(0.09 0.05 min', /3-ATP peak, N = 3). These changes are consistent
with a model of the "average" renal cell having a very high membrane
permeability and with steady state cations maintained solely by active
transport in the ratio, Na :K :ATP = 3:2:1. Hypoxic inhibition of ATP
synthesis allows passive K effiux and Na influx to occur with initial
rate constants given by the same ratio, suggesting that membrane cation
permeability is not directly altered by hypoxia.
1. Hochachka PW: Science 231 :234—241, 1986
Rb Nuclear magnetic resonance (NMR) measurement of K flux in
intact kidney. Z.H. Endre, J.L. Allis, G.K. Radda, Department of
Medicine, University of Queensland, Australia, and Department of
Biochemistry, University of Oxford, United Kingdom. To measure
K-related fluxes in intact kidney we developed 87Rb NMR using
single-pass Krebs bicarbonate buffer (KHB) perfusion of the isolated
rat kidney (IPRK).' As low perfusate flow and oxygen delivery impair
Na and K reabsorption in this preparation, we extended the method
using the albumin-supplemented recirculating IPRK, Right kidneys
from Wistar rats were perfused as 37°C with KHB containing 6.7 g%
bovine serum albumin (BSA), 20 amino acids, 5 mM glucose and gassed
with 95% 02, 5% CO2. Kidneys were placed within an "earphone"
radiofreqeuncy coil (59.86 MHz) and perfused in a 4.3T vertical bore
Oxford magnet. After 30—45 mm baseline perfusion RbCI was added to
1.5 m and 87Rb spectra were acquired sequentially in 4 mm blocks
(20,480 scans per spectrum). The data were analyzed non-linearly using
a 2 compartment model assuming a contant rate of active inward Rb
transport and independent inward (k+,) and outward (k,) rates of
passive diffusion. The initial uptake (v + K,Io, where lo = extracel-
lular Rb) was scaled to reflect K transport assuming direct replace-
ment of K by Rb. Allowing for reduced (42%) NMR-visibility of renal
87Rb gives an inward flux of 9.1 0.8 (SD, N = 3) tmol/min/g wet
kidney, which compares well with published values for 42K uptake in
isolated tubules and cortical slices. Even higher values result when the
40% intrarenal extracellular space is considered. Although Rb and K
are handled identically by NaKATPase, 87Rb is much more NMR-
sensitive than 39K, allowing enhanced S/N and reduced temporal
resolution.
1. Endre ZH, Allis JL, Ratcliffe PJ, et al: Biochem Soc Trans 16:
596—597, 1988
Comparison of red cell volume distribution by Coulter counter (CC) to
phase contrast microscopy (PCM) in the differentiation of glomerular (G)
from non-glomerular (NG) hematuria. K. Fairley, W.M. Bennett, S.
Fairley, D. Birch, Department of Nephrology, Royal Melbourne Hos-
pital, Victoria, Australia 3050. PCM is a sensitive technique to distin-
guish G from NO hematuria. Recently, Schichiri et al reported similar
results using automated red cell sizing with a CC to eliminate observer
variability (Lancet 1:908, 1988). The sensitivity of these techniques was
compared using midstream urine samples from 44 patients with >io
rbc/ml. Bleeding was classified as NO by PCM if there was a uniform
isomorphic cell population and by CC if there was a distribution peak of
cells >75 /sm3. 0 bleeding was diagnosed by dysmorphic red cells on
PCM and a unimodal or bimodal red cell population <75 m3 on CC.
The phase microscopist was blinded to the clinical diagnosis or CC
results. Twenty-seven patients had a single NO bleeding source. Three
patients had both 0 and NO sources. Number of correct diagnosis and
(%):
N PCM CC
0 27 26 (96) 24 (89)
NO 14 14 (100) 10 (71)
Only PCM was successful in identifying 2 simultaneous bleeding
sources. Conclusion: Both techniques have excellent senSitivity for G
hematuria; however, PCM microscopy is more accurate for NG
sources. PCM and CC are simple, inexpensive ways to avoid unneces-
sary invasive procedures. PCM is recommended to confirm 0 obtained
by CC to avoid overlooking small isomorphic cells which require
urologic studies.
Causes of graft loss and three-year results In renal transplant recipients
managed with cyclosporin A. E. Savdie, J.M. Hayes, J. Kelly, M.
Ralston, Renal Unit and Department of Anatomical Pathology, St.
Vincent's Hospital, Sydney, Australia. Since October, 1984, 40 consec-
utive recipients of 41 cadaver grafts (32 first, eight second and one third)
have been managed with prophylactic cyclosporin A, either in combi-
nation with low-dose prednisolone, or as part of a triple therapy regime
(from August, 1987) combined with low doses of both prednisolone and
azathioprine. After January, 1988, acute rejection not responding to
pulse steroid therapy was treated with Orthoclone (muromonab CD3).
As of October, 1988, there had been a single death, due to Pneumocys-
tis pneumonia. There were six others who lost their grafts, all within the
first three months, so that the actuarial graft survival after one year
(82%, SE 7.9) remained unchanged after two and three years. One graft
came from a donor who, in retrospect, had disseminated intravascular
coagulation; the graft remained blue and soft after re-anastomosis in the
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recipient and was removed. Two grafts were lost within 72 hours due to
graft vein thrombosis, of the main renal vein in one case and the renal
vein tributaries in the other. One recipient had a coagulopathy post-
transplant and lost his graft because of hemorrhage around and beneath
the renal capsule and around the periureteric venous plexus, which was
thrombosed. In two cases graft loss was due to rejection, predominately
vascular. These results indicate that, in patients managed with cyclos-
porin A, (i) cyctosporin-related thrombotic syndromes are a more
frequent cause of graft loss than rejection, and (ii) graft survival beyond
the early months is maintained, no further attrition being demonstrable
up to three years.
Murine anti-CD3 MAB: Effective immunoprophylaxis inducing non-
specific tolerance. J.D. Mackie, O.G. Pankewycz, M. Bastos, V.E.
Kelley, T.B. Strom, Beth israel Brigham and Women's Hospitals,
Harvard Medical School, Boston, Massachusetts, USA. Anti-CD3
mAb therapy has proven to be effective anti-rejection therapy, how-
ever, the potential for use in pancreatic islet cell transplantation is yet
to be established. In this report we examine the therapeutic role of the
hamster anti-mouse CD3 mAb, 145-2C 11, in pancreatic islet transplan-
tation. Crude pancreatic islet preparations, collagenase digests from
DBA/2J mice (H-2'1) are transplanted into diabetic B6AF1, (H-2"')
mice. The strain combination presents strong histocompatibility barri-
ers. Treatment with 50, 5 or 0.5 sg (=20 sg/kg) i.p/d xl5 prolongs graft
survival (P < 0.005, N = 6/group). During therapy transplants are not
rejected as assessed by return of hyperglycemia. Long-term graft
survival, (>100 days) occurs in 33 to 50% of anti-CD3 treated animals,
this does not appear to be dose related. Rechallenge of long-term
survivors with donor strain antigens (splenic leukocytes) results in rapid
graft rejection (<10 days) in all cases (N = 4), indicating that the donor
specific tolerance has not been induced. Transfer of splenic leukocytes
from long-term survivors to de novo transplants does not influence graft
survival, suggesting that suppressor cells are not functionally important
in long-term graft survival. Murine anti-CD3 is a potent prophylactic
immunosuppressive agent for islet cell transplantation, inducing a state
of donor non-specific tolerance. This model may prove useful in
studying the dose related effects of anti-CD3 treatment in human islet
transplantation.
Renal metabolism of cyclosporin A (CsA) may contribute to nephro-
toxicity. R.J. Walker, V.A. Lazzaro, G.G. Duggin, Royal Prince Alfred
Hospital, Camperdown NSW 2050, Australia. Hepatic mixed function
oxidases (MFO) metabolizing CsA are subject to noncompetitive inhi-
bition by CsA.' Renal MFO are located in the S3 segment of the
proximal tubule. CsA tubulotoxicity is confined to this segment, sug-
gesting renal metabolism of CsA may be important in generating
toxicity. Renal MFO activity and lipid peroxidation was investigated
comparing CsA fed rats (50 mg/kg/day 4 days) with olive oil vehicle-fed
rats. Hepatic and renal microsomes were obtained by differential
ultracentrifugation. NADPH cytochrome C reductase (NCR) (an essen-
tial component of MFO activity) enzyme kinetics were compared
between vehicle and CSA microsomes. Renal microsomal peroxidation
was measured as the rate of malondialdehyde (MDA) formation.
Hepatic NCR Renal NCR
E; Km Vmax Enz Km Vmx
nz
Veh. 237 1.85 457 34.0 1.0 47.7
CsA 150 0.48 163 31.1 0.53 35.4
Difference in enz. activity (renal) P < 0.01
MDA formation (nmol/60 mm/mg) Mean (saM) N = 12
Vehicle 1.53 0.08
CsA 2.15 + 0.19 (P < 0.01)
CsA significantly increases renal microsomal peroxidation and inhibits
(uncompetitive) NCR activity. Renal MFO activity is 5- to 10-fold less
than hepatic activity. Changes in renal MFO activity will therefore have
greater effects for a given degree of enzyme inhibition. Increased lipid
peroxidation may further alter the CsA bound MFO membrane complex
leading to greater inhibition of renal MFO activity. Renal CSA metab-
olism, therefore, may be important in CSA nephrotoxicity.
I. Augustine JA, Zemaitis MA: Drug Melab Dispos 14:73—8, 1986
The New Zealand Glomerulonephritis Study: I. Introductory report
with five year followup. T.J. Neale, R.R. Bailey, S.F. Hannan, L.C.
Williams on behalf of the New Zealand Glomerulonephritis Study
Group. Glomerulonephritis (GN) is the most common cause of end-
stage renal failure in NZ. From July 1, 1972 to June 30, 1983 patients
aged 14 years with biopsy-proven GN were entered into a central
register: a total of 803 patients from 85% of the at risk population in this
age group (75% of the 189,900 Polynesians). All biopsy material was
subjected to a uniform independent evaluation (Mayo Clinic). The
incidence of ON in men was more than twice that in women, particu-
larly for post-infectious GN, IgA nephropathy, anti-glomerular base-
ment membrane antibody-initiated ON (AGBM) and membranous
nephropathy: age-adjusted relative risk for males >3.1. Polynesians
(predominantly Maoris) had a higher overall incidence of GN than New
Zealanders of European descent (P < 0.001) particularly for MCGN,
FGS, post-infectious, crescentic and AGBM where the Polynesian
relative risk ranged from >5 to 1.58. The incidence of IgA nephropathy
was reduced in Polynesians (relative risk = 0.49). The racial difference
in the incidence of GN may account in part of the known higher rate of
end-stage renal failure in Polynesians. At five years 204 patients (25.4%)
had notional renal death (entry into a dialysis-transplant program, death
from renal failure), with a median time of 1.10 years. An adverse
outcome, including non-renal death was more frequent in Polynesians,
there being a significant difference in survival versus non-Polynesians
(Rank test for homogeneity, P = 0.0223). Follow-up is continuing, to
define the long-term outcome of patients within each histological
category of GN and to determine any potential prognostic factors.
Localization of anti-basement membrane-binding polyclonal antibodies
in rat lung and kidney using post-embedding immunogold electronmicros-
copy. N.S. Fernando, T.J. Neale, N. W. Boyce, S.R. Holdsworth,
Department of Medicine, Wellington School of Medicine and Depart-
ment of Medicine, Prince Henry's Hospital, Melbourne, Australia.
Anti-glomerular basement membrane, antibody-induced nephritis
(AGBM) may be associated with antibody binding to lung basement
membrane. Models of AGBM have been established in experimental
animals using heterologous antibodies raised against GBM. Anti-lung
models have been more difficult to induce. Previous studies have
suggested that the nephritogenic capacity of an antibody is determined
by its ability to activate mediator systems. However, immunoglobulin
to GBM antigens can directly alter glomerular permselectivity in the
absence of mediators. It was therefore of interest to locate the binding
sites of nephritogenic and non-nephritogenic anti-GBM antibodies and
of a relevant anti-lung reagent. Polyclonal antibodies raised against rat
kidney basement membranes and a rat lung preparation were localized
as to their binding sites in both organs, in vivo, by immunogold electron
microscopy using low temperature embedding in LR white resin. A
nephritogenic anti-GBM antibody (P1) localized in a bilaminar linear
pattern along the subepithelial, and particularly the subendothelial,
aspect of the OBM. A non-nephritogenic anti-GBM antibody (P2)
bound diffusely throughout the lamina densa, even at supra maximal
doses. The anti-lung antibody bound in an interrupted linear pattern
throughout the lung basement membrane, and in an intense, diffuse
pattern to the GBM. The precise binding site of anti-basement mem-
brane antibodies may in part determine their individual inflammatory
potential.
Evidence that aluminium absorption by the rat duodenum is energy
dependent. M. Cochran, G. Goddard, Renal Unit Flinders Medical
Centre, South Australia. We have perfused the duodenum of anesthe-
tized male rats with perfusate (pH 8.5) to which A1C13 had been added
across the range [Al] 0 to 150 sM. In groups of 5 rats, we tested the
effect of the metabolic inhibitors NaCN 1.0 m and 2:4 dinitrophenol
0.1 m in the perfusate. Two further groups of rats were tested after
colchicine (25 sg) or vinchristine (10 g) in I ml 0.15 M saline was given
into the femoral vein, 3 hr before commencement of perfusion. Five
control animals were perfused without the inhibitors. These perfusions
were carried out at [Al] 150 LM. Al uptake increased with the perfusate
[Al] with a second order, decreasing relationship that was significantly
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different from linearity. When the data are expressed as clearances, in
control animals the mean value was 187 0.022 mI/min/g duodenum.
After NaCN and DNP, the clearances were 0.041 0.011 and 0.088
0.012 ml/min/g duodenum, respectively, which is significantly different
from control values; after coichicine and vincristine they were 0.200
0.040 and 0.132 0.012 mI/min/g duodenum, respectively (not signifi-
cant). The uptake of water amounted to 20% for control animals, but
with the metabolic inhibitors and after colchicine or vinchristine, we
saw no net water uptake. The results indicate that a significant
component of Al absorption from low concentrations of the metal at
normal duodenal alkalinity takes place by an energy dependent process.
This uptake is not affected when agents that reduce pinocytosis are
introduced, even though there is a reduction in water absorption.
Interrelationship of isotopic and hIstological bone formation rate in
maintenance dialysis patients. M. Cochran, M. Nicholson, A. Neville,
E.A. Marshall, Renal Unit, Flinders Medical Centre, South Australia
and Department of Mathematics, University of Sheffield, United Kin g-
dom. Bone mineralization rate (m) measured with 47Ca has been
compared with the concurrent histological bone formation rate (BFR)
estimated on iliac crest biopsies after double tetracycline labelling in 20
maintenance dialysis patients. The former is a calculated rate of uptake
of Ca (mmol/day) by the skeleton, whereas the latter is the rate of
fractional replacement of bone volume in the trabecular bone specimen.
Standard histomorphometric measurements and biochemical values
were also obtained. We found very high degrees of correlation between
the two independent estimations of bone formation rate. The r value
exceeded 0.85 for: m, BFR; m, alk p'ase; m, PTH. The bone apposition
rate also correlated with PTH, r = 0.71. None of the biochemical or
dynamic parameters correlated with minearlization lag time. When the
volumetric BFR is converted to an approximate mineralization rate,
using literature values for mineral density of new bone, the isotopic and
morphological methods agree closely, endorsing the validities of both
techniques. The correlation between m and PTH means that secondary
hyperparathyroidism creates a drain on the serum calcium pool. Any
level of bone resorption has to be raised at least to match the
mineralization rate. Thus renal secondary hyperparathyroidism is an
inefficient mechanism for maintaining the serum calcium, which helps
to explain why progressive over-activity is commonly observed.
Inhibition of protein kinase C activation by low concentrations of
aluminium. M. Cochran, D.C. Elliott, Renal Unit, Flinders Medical
Centre, and Biological Sciences, Flinders University, SA 5042. Alumin-
ium has been shown to modify the characteristic properties of synthetic
phospholipid membranes, which led us to study its effect on phospha-
tidylserine (PS) activation of protein kinase C (PKC). PKC was
extracted from Amaranthus tricolor seedlings with two stage purifica-
tion, and activation of PKC was estimated by the rate of hydrolysis of
labelled ATP at 25°C in the presence of PS and the chosen [Cal and [Al].
The interaction of the cations and ligands was taken into account when
determining the free cation concentrations for the experiment, but it
was impossible to have an exact estimate of 1Al3] in the system, owing
to its complex physical chemistry. Activation of PKC was maximized
by an li-fold increase in Ca (0.08—0.90 mM). The effect of increasing
[Al] consistently reduced PKC activity at three [Ca], namely 0.12, 0.6,
and 1.2 mM. At limiting [Ca] (0.12 mM), [Al] 0.6 m abolished PKC
activity; at non-limiting [Ca] (0.6 mM), [Al] at 0.8 m reduced PKC
activity 50%; at excess [Ca] (1.2 mM), [Al] at 1.25 m reduced PKC
activity 50%. These results show clearly that Al in low concentrations
will reduce the activity of the PS-PKC-Ca system though the exact
point at which the effect takes place has not been defined. It should be
noted that the true [Al3] will be extremely low in this sytem, of the
order of 10—10 M.
Utero-placental ischemia In conscious unrestrained pregnant baboons
(P. Hamadryas), A model for pre-eclampsia? A. Gillin, A. Phippard, J.
Horvath, J. Thompson, D. Tiller, Department of Renal Medicine,
Royal Prince A'fred Hospital, Camperdown, NSW 2050, Australia. The
ischemic kidney and ischemic placenta have long been associated with
the etiology of hypertension. In contrast to the evidence concerning
renal ischemia, the role of placental ischemia remains unproven. At
present there is no animal model of pregnancy induced hypertension or
pre-eclampsia, either spontaneous or experimentally induced. Numer-
ous technical difficulties have confounded attempts to develop a pri-
mate animal model based upon placental ischemia. In the chronically
prepared conscious pregnant baboon, trained and equipped with a
backpack for instrumentation we have extended previous observations
of elevated blood pressure in unconscious baboons. Induction of
premature labour as a result of surgical stress has been overcome by
perioperative 4-OH-Androstenedione to inhibit the placental surge in
estrogens that induce labour. Digital subtraction arteriography of the
uterine vasculature has demonstrated that each uterine artery subserves
a discrete portion of the baboon placenta. Knowledge of each subject's
placental blood supply leads to the most effective site of surgical
interference, and we have demonstrated that unilateral uterine artery
ligation overcomes placental reserve without fetal demise. This ap-
proach has produced a more stable preparation of longer duration than
previously reported in baboons. These animals develop sustained
hypertension, marked thrombocytopenia, hypoalbuminemia as well as
proteinuria. All these abnormalities resolve following delivery. Placen-
tal histology shows evidence of ipsilateral ischemia on the fetal side,
without thrombosis or infarction on the maternal side, extending the
analogy of the ischemic kidney and placenta. This improved animal
preparation is a significant advance over those previously reported and
is approaching a "model" for the human syndrome of pre-eclampsia.
Combined renal and hepatic transplantation in a young man with
primary hyperoxaluria—A definitive cure. J. Ens, D. Tiller, G. Mc-
Caughan, J. McDonald, N. Gallagher, J. Horvath, G. Duggin, J.
Thompson, M.S. Stephen, A.G.R. Sheil, Department of Renal Medi-
cine and Liver Transplant Unit, Royal Prince Alfred Hospital, Camp-
erdown, Australia. Primary hyperoxaluria comprises three inborn er-
rors of metabolism. These errors result in the excretion of excessive
oxalate and the formation of renal stones. If renal failure develops,
dialysis cannot sustain the patient's life, with progressive deposition of
oxalate leading to cardiac and peripheral vascular insufficiency. Renal
transplantation is usually unsuccessful because of rapid deposition of
calcium oxalate in the graft and subsequent graft loss. A 26-year-old
man with known renal calculi for 15 years, but in whom the diagnosis of
primary hyperoxaluna had not been made, developed acute renal
failure following attempted stone removal and septicemia. Renal func-
tion failed to improve on dialysis and his peripheral pulses became
impalpable. A nerve biopsy for acute peripheral neuropathy revealed
extensive vascular infiltrates of oxalate. Enzyme assay of a liver biopsy
revealed type I primary hyperoxaluria with low levels of alanine:
glyoxylate aminotransferase. Despite 6 hemodialysis/hemofiltration
procedures each week, combined with plasma pheresis, he developed
arthropathy, progressive peripheral neuropathy and vasculopathy with
digital gangrene. The onset of malignant arrhythmias necessitated an
indwelling cardiac pacemaker. A combined liver and kidney transplant
was performed on 19.10.88. Both grafts functioned immediately, his
peripheral pulses returned and his peripheral neuropathy improved over
several weeks. Arrhythmias resolved. His serum creatinine is now 120
molIliter and his liver function is normal. Combined liver and renal
transplantation have successfully reversed all the changes of acute renal
failure and oxalosis by restoring his source of alanine: glyoxylate
aminotransferase.
Cyclosporin A versus azathioprine and prednisone. An eight year
follow-up in cadaver renal transplantation. D. Tiller, J. Horvath, G.
Duggin, A. Phippard, J. Johnson, J. Thompson, M. Stephen, J. Harris,
A. Sheil, Department of Renal Medicine, Royald Prince Alfred Hospi-
tal, Camperdown, Australia. In 1980 an open, prospective randomized
study was commenced to compare cyclosporin A (C5A) with 'best'
conventional therapy using azathioprine, prednisone and antilympho-
cyte globulin (Aza). Both first and subsequent cadaveric grafts were
entered. 94 patients were entered between September 1980 and Decem-
ber 1982. 48 patients received CsA and 46 Aza. Patients receiving CsA
and Aza were commenced on therapy whether or not they were
oliguric. CsA dosage commenced at 17 mg/kg/day orally, reducing to 10
mg/kg/day by day 50. The Aza group received azathioprine 3 mg/
kg/day, reducing to 2 mg/kg/day and prednisone 500 mg/day reducing to
20 mg/day at day 30. Cox's proportional hazard model was used to
assess variables at transplantation affecting graft and patient survival,
including the caring medical officer, the treatment group (Aza vs. CsA),
sex, age, weight, transplant number, and underlying renal disease of the
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patients and whether they had >10% cytotoxic antibodies prior to
transplantation. Age was significantly (P < 0.0001) related to patient
survival. The presence of cytotoxic antibodies was related to graft
survival (P = 0.031). There did not appear to be any effect on patient or
graft survival by any of the other factors assessed. In conclusion, as
with the national data, age is a significant factor in patient survival.
Cytotoxic antibodies diminish the chance of long-term kidney survival
that is unaffected by the two different treatment regimes.
Effect of long and short term adrenalectomy of ADH-stimulated water
transport of the rat papillary collecting ducts. C.D. Ray, S.L. Carney,
A.H.B. Gillies, Faculty of Medicine, University of Newcastle, NSW
2308, Australia. Adrenal insufficiency is associated with an impairment
in the regulation of salt and water excretion. Although the dehydration
sometimes found in long-term adrenal insufficiency is thought to be due
to salt depletion, hypoadrenal patients are also unable to generate a
maximally concentrated urine as well as having a reduced ability to
excrete a water load. While aldosterone does not directly or acutely
affect water transport in vivo or in vitro, the short (<7 days) and long
(4 weeks) term effects of adrenalectomy on water transport in the rat
papillary collecting duct was evaluated using micropuncture of the
isolated rat papilla. A submaximal concentration of ADH (20 U/ml)
increases water permeability from 3.88 0.25 sm/sec to 4.66 0.26
mIsec. Short term adrenalectomy does not affect this response to
ADH (4.26 0.22 smIsec to 5.26 0.29 anIsec). However, long term
adrenalectomy inhibits the action of submaximal concentrations of
ADH (4.31 0.22 pm/sec to 4.31 0.24 sm/sec). This inhibition is
overcome by using a supramaximal concentration of ADH (2000
tU/ml). The increase in water permeability of normal collecting ducts
being 2.86 0.88 pnilsec compared to 3.54 1.13 pm/sec for papillae
from long term adrenalectomized rats. These results suggest that
adrenal hormones (presumably aldosterone) do facilitate the action of
ADH upon collecting duct water transport, probably by a direct effect
upon collecting duct receptors.
Relative contributions of chemoattractant and terminal components of
complement to anti-GBM glomerulonephritis. N. W. Boyce, PG. Tip-
ping, S.R. Holdsworth, Department of Medicine, Prince Henry's
Hospital, Melbourne, Victoria 3004, Australia. Normal rabbits (com-
plement intact) given anti-GBM antibody, at a dose which resulted in
140 tg specific kidney fixed antibody per gram of renal cortex,
developed significant proteinuria (1910 327 mg/24 hr, control 18.2
6.1 mg/24 hr; P < 0.01). Leukocyte depletion significantly reduced but
did not abolish proteinuria (574 186 mg/24 hr, P < 0.05). Complement
depeletion of neutrophil depleted rabbits resulted in a further significant
reduction in proteinuna (50.1 12.2 mg/24 hr, P < 0.05; c.f. neutrophil
depleted, complement intact rabbits), indicating that both neutrophil
accumulation and complement activation independent of neutrophils
contribute to injury in this model. Rabbits congenitally deficient in the
sixth component of complement (C6D) developed similar levels of
proteinuria (2099 796 mg124 hr) to normal rabbits given an identical
dose of antibody. However, after leukocyte depletion, C6D rabbits
developed significantly less proteinuria (135 56 mg124 hr) than
leukocyte depleted, complement intact rabbits (P < 0.05). These
studies show that terminal complement components are not necessary
for the full expression of acute anti-GBM antibody initiated injury in
leukocyte intact rabbits. However, in the absence of leukocytes, C6 and
the terminal complement components are responsible for the majority
of the complement-dependent glomerular injury.
Effect of human parathyroid related protein on rat renal function:
Comparison with human parathyroid hormone. S.L. Carney, P.R.
Ebeling, T.J. Martin, A.H.B. Gillies, Faculty of Medicine, University of
Newcastle and the University of Melbourne, Australia. Studies of
humoral hypercalcemia of malignancy (HHM) have demonstrated a
parathyroid hormone related protein (hPTHrP) with a 13 amino-ter-
minal residue identical with human parathyroid hormone (hPTH).
Several studies have suggested that hPTHrP has a greater biological
activity than PTH particularly when cAMP generation from bone cells
has been evaluated. Its effect on renal calcium transport is unclear with
evidence of reduced as well as increased calcium transport. Conse-
quently hPTHrP was compared to hPTH in an anaesthetised thyropara-
thyroidectomized rat model using maximal (1 pg/hr), sub-maximal (0.1
pg/hr) and supramaximal (2 sgIhr) concentrations of both hormones
and evaluating their effect on renal excretion of Na, K, Ca, Mg, P04,
cAMP and urine pH. Maximal concentrations of hPTHrP and hPTH
produced a similar phosphaturia (20.3 1.6% compared with 18.7
1.8%) and produced similar reductions in the excretion of Ca (69.8%
compared with 69.5%) and Mg (67.8% and 67.1%). Urinary cAMP
excretion rates were also similar. Supramaximal concentrations of
these hormones did not significantly alter the above results. Sub-
maximal concentrations were again not significantly different from one
another. For example, FEPO4 was increased from 0.1 0.1% to 1.9
0.3% in the hPTHrP group and from 0.1 0.1% to 2.3 0.4% in the
hPTH group. Also PTHrP and PTH produced a brief reduction in FE
water. It is concluded that both hormones have a similar effect on renal
electrolyte transport.
Acute pancreatitis and rhabdomyolysis. B.J. Nankivell,Department of
Nephrology, Royal Newcastle Hospital, N.S. W. 2300, Australia. Four-
teen cases of acute severe pancreatitis with nontraumatic rhabdomyo-
lysis, a hitherto undescribed association, occurred over an eight year
period. The pancreatitis was of various etiologies, severe (with an
average Ranson score of 7.4), and was confirmed by surgical diagnosis,
laparotomy, abdominal paracentesis, CAT scan and post-mortem.
Rhabdomyolysis, defined by a plasma creatine phosphokinase (CPK)
greater than 900 lU/liter, in which myocardial infarction has been
excluded, occurred from 2 to 19 days after onset of pancreatitis. Mean
CPK peak was at 8 days. Severe rhabdomyolysis with myoglobinuria
and renal failure occurred in 3 cases, with acute renal failure occurring
in a further 9 others. In most cases the presence of rhabdomyolysis did
not influence the renal outcome. Hypocalcemia (corrected calcium
below 1.8 mmollliter) was noted in 13 patients, remaining abnormal for
5.2 0.8 days and reaching an average minimum of 1.75 0.08
mmol/liter. Intravenous calcium supplements were given to half the
patients. Multiple organ failure developed in 93% of cases and was
present in 79% of patients at the time of maximal CPK peak. Eleven
patients died. A possible mechanism of rhabdomyolysis and multiple
organ failure is absorption of digestive enzymes, cellular debris, inflam-
matory cells and chemical mediators into the circulation, occurring
several days after onset of pancreatitis. Rhabdomyolysis is commonly
associated with severe acute pancreatitis, appearing as a late phenom-
enon, in the context of severe prolonged hypocalcemia, multiple organ
failure and poor outcome.
Neopterin quantitation provides further evidence of the participation of
cell mediated immunity (CMI) in human glomerulonephritis (GN). T.J.
Neale, J. Hill, R. Cooke, Department of Medicine, Wellington School
of Medicine and Department of Radiochemistry, Wellington Hospital,
Australia. We have recently demonstrated the simultaneous occurrence
of all elements of a delayed type hypersensitivity response (T cells,
macrophages, procoagulant human tissue factor, and fibrin) within the
glomeruli of patients with aggressive GN (Lance! ii:421—424, 1988),
strongly suggesting a role for CMI. In the current study, we sought
functional evidence of CMI involvement in GN by measuring neopterin/
creatinine ratios (smol/mol) in renal patients with and without GN,
using sensitive HPLC (urine) and RIA (plasma) methods. The HPLC is
sensitive to 30 nmol/liter and the RIA to 1.25 nmollliter. Neopterin is a
pyrazino pyrimidine metabolite derived from guanosine triphosphate
and is a specific marker of the activation of macrophages by sensitized
T cells via gamma interferon. As such, neopterin is a sensitive indicator
of CMI participation in biological processes. Biopsy-proven GN pa-
tients (16) with no overt evidence of malignancy or infection, all with
impaired renal function and aggressive histology showed a median
neopterinlcreatinine ratio in urine (HPLC) of 433. Non-nephritic pa-
tients (12) had a median ratio of 88 (P < 0.001, Mann-Whitney U test).
In another group of nephritic patients (14) the median plasma (RIA)
neopterin/creatinine ratio was 152, and in non-nephritic controls (8) was
70 (P < 0.001). Neopterin measurements further implicate CMI in the
immunopathogenesis of aggressive GN in man.
Quantitative fluorescence measurements detect multiple antigenic
changes due to IFN-gamma on human macrophage cell lines. N. Kraft, P.
Hutchinson, A. Spry, S. Senes Ferrari, R.C. Atkins, Department of
Nephrology, Prince Henry's Hospital, Melbourne 3004, Australia. The
severity of several forms of nephritis is correlated with the extent of the
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associated leukocytic infiltrate. This infiltrate comprises mainly two
populations: T lymphocytes and macrophages. While it is possible to
study the lymphocytes by immunohistology because of the availability
of subpopulation and activation markers, the investigation of macro-
phage function is hindered by the general absence of such reagents. We
have sought to develop an alternative approach to define the activated
macrophage by establishing a "phenotypic response profile" based on
quantitative changes of known myeloid antigens following activation
with gamma interferon (IFN-G). As freshly harvested monocytes gave
highly variable results when quantitative phenotypic measurements
were made, we used two macrophage-like cell lines: U937 and Rc2A in
order to avoid prior stimulation of cells by unknown factors in viva. Ten
separate experiments showed that cell surface antigens could be mea-
sured with precision (mean channel fluorescence value (MCF) for CDI3
antigen 125.5 5.2 SD) and that some antigens were affected consis-
tently by activation (Rc2A MHC I antigen increased from 94 13 MCF
to 151 15). Of the 123 antibodies tested, 27 repeatedly detectable
changes (10 to 100% in MCF or % + ye) following activation. Examples
of the antigens which were affected include CD45, CD45R, MHC1,
MHC2, and CD25. Of these only the last two have been well established
previously. While some antigens were changed by activation on both
cell lines and on monocytes other changes were confined to one line.
This raises the question of limited response repertoires in a given
differentiation stage and perhaps suggests a means of defining myeloid
cell lines within a differentiation sequence.
Idiopathic membranous nephropathy: Natural history and thromboem-
bolic complications. R. Bellomo, C. Wood, I. Wagner, J. Agar, J.
Dowling, N. Thomson, R.C. Atkins, Department of Nephrology, Prince
Henry's Hospital, Melbourne 3004, Australia. To study the natural
history of idiopathic membranous nephropathy in an Australian popu-
lation and to assess the incidence of thromboembolic complications and
their impact on the clinical course of this disorder, we retrospectively
reviewed the medical records of 71 biopsy proven cases of primary
membranous nephropathy from Prince Henry's Hospital between 1973
and 1988. There were 55 males and 16 females (average age 50.0 15.3
years); 47 patients (66.1%) presented with nephrosis. The 5 year
survival was 84%, 77% at 10 years. Dialysis-free renal survival was
81.1% at 5 years and 60.6% at 10 years. Staging on renal biopsy was not
predictive of outcome; 16 patients received immunosuppressive treat-
ment (22%). Their clinical course appeared no different from that of
untreated patients, however, the nephrotic syndrome was more com-
mon (P < 0.01) at presentation in the treated group. Spontaneous partial
remission occurred in 18 patients (25.7%) and in 5 of these it was
complete. Thromboembolic events occurred in 12 patients (21 events).
They were particularly common in the first 6 months (16 events),
Directly or through the complications of anti-coagulation they caused
40% of all deaths. They occurred more frequently (P < 0.01) in patients
with a serum albumin below 25 g/liter at presentation. As expected,
patients who died experienced more thromboembolic events (P < 0.01)
and had a significantly lower serum albumin (P < 0.001). This study
confirms the relatively benign natural history of membranous nephrop-
athy and highlights the need for early prophylactic anti-coagulation in
patients presenting with a low serum albumin.
Cell-mediated pulmonary injury In experimental Goodpasture's syn-
drome in the rat. H. Y. Lan, P. Hutchinson, R.C. Atkins, Department of
Nephrology, Prince Henry's Hospital, Melbourne 3004, Australia.
Pulmonary hemorrhage in Goodpasture's syndrome results from depo-
sition of anti-basement membrane (BM) antibody on the alveolar
capillary (CBM). We set up a Goodpasture's syndrome model in rat to
delineate the cellular components in this disease. Infiltrating cells in the
lung were analyzed and quantitated by flow cytometry and immunohis-
tochemistry using monoclonal antibodies. A linear deposition of anti-
BM antibody was found in both glomerular and alveolar CBM as early
as 1 hr post-injection of nephrotoxic serum into an IgG-primed rat. Mild
to moderate pulmonary hemorrhage was evident at 12 hrs. Total
leucocytes (OX-I + ye) increased with time and the degree of pulmo-
nary damage. The majoirty of these cells were EDI + ye macrophages.
Numerous IgG + ye and C3 ÷ ye (probably Fc and C3b receptor)
monocyte/macrophages were located within and surrounding blood
vessels. The number of EDI + ye cells markedly increased from 140
38/mm2 (19% of OX-I + ye) in control rats to 986 184/mm2 (58% of
OX-i + ye) at 12 hrs post-injection, and then did not significantly alter
over day I to day 28 (973 192/mm2). Severity of pulmonary hemor-
rhage correlated with the intensity of the monocyte/macrophage infil-
trate. Other components of the infiltrate included CD4 + ye (W3/25) and
to a lesser extent CD8 + ye (OX-8) cells. CD4 + ye cell numbers were
elevated at 12 hrs (539 243/mm2 cf 250 23/mm2 in control rats) and
then gradually increased to 705 13/mm2 (45% of OX-I + ye) on day
28 (CD4 labelling includes some macrophages as well as T cells).
Almost all cells (>90%) infiltrating in perivascular areas expressed the
I-E antigen (MHC class II). This study has demonstrated that macro-
phages are the major leucocyte involved in the pathogenesis of lung
damage in a fashion similar to that seen in glomerular injury in this
disease.
Evolving pattern of the interstitial leucocyte infiltrate in experimental
anti-GBM glomerulonephrltis (GN). H. Y. Lan, D.J. Paterson, R.C.
Atkins, Department of Nephrology, Prince Henry's Hospital, Mel-
bourne 3004, Australia. Most forms of ON are associated with an
interstitial leucocytic infiltrate and this is particularly prominent in
anti-GBM disease. Using a primed anti-GBM model in the rat, intersti-
tial leucocytes were characterized by monoclonal antibodies from 12
hrs to 28 days after injection of nephrotoxic serum. At 12 hrs,
infiltrating interstitial leucocytes were restricted to a sheath surround-
ing the hilar arterioles: of these total leucocytes (229 2.4/mm2:
OX-H-), the majority were CD4+ T cells (136 30/mm2) with EDI+
macrophages (66 5.4/mm2) a minor component. By day 3, the
infiltrate encircled the glomeruli (695 142/mm2 OX-I+) and became
widespread throughout the whole cortical peritubular area by day 7(343
84/mm2 OX-I + cf 76 32/mm2 in control rats). Medullary infiltrate
appeared at the cortico-medullary junction at day 7 and was seen
throughout the medulla by day 14. The peak of infiltration was evident
at day 21(1388 88/mm2 OX-i + cells) and at all stages of evolution
CD4+ T cells dominated (69 to 90% of OX-i + cells). The striking
features of the pattern of interstitial infiltrate in this model are: (1) initial
localization of the infiltrate to a hilar arteriolar sheath; and (2) the
intensity of the widespread interstitial infiltrate with the dominance of
CD4+ T cells. Deposition of rabbit antibody was not detected in the
arteriolar wall or sheath areas, whether this interstitial infiltrate is
directed by sensitized T cells as in the rejection process, or is due to a
diffusion of chemotactic cytokines from the injured glomerulus, remains
to be determined.
Effect of human recombinant interleukin-1 on the proliferation of rat
mesangial cells in culture. V. Kakizaki, N. Kraft, R.C. Atkins, Depart-
ment of Nephrology, Prince Henry's Hospital, Melbourne 3004, Aus-
tralia. It has been reported that interleukin 1 (IL-i) purified from
macrophage or mesangial cell (MC) culture supernatants stimulate MC
proliferation in logarithmic growth phase. However, only limited data is
available on the effect of recombinant (human) IL-l on MC prolifera-
tion, minimal effects having been described for cells of mouse and rat
origin. We have examined the response of rat MC to rIL-l on cells in
logarithmic growth phase and in confluency by measuring 3H-thymidine
incorporation after 2, 4 and 6 days of culture. Human rIL-l had no
effect on MC proliferation in logarithmic growth phase in 20% or 5%
FCS, and also did not affect proliferation following release from
growth-arrest. Cells in confluent cultures had reduced thymidine incor-
poration, but added rIL-l increased this significantly (56 to 142%
increase at day 6 with 1000 U/mI). However, unlike the effects seen with
epidermal growth factor, rIL- I did not appear to completely overcome
the effect of contact inhibition. Rather it tended to maintain the rate of
thymidine incorporation at the level present at the time of rIL- I
addition. This suggests that IL-I may act to reduce the number of cells
entering the contact inhibition phase and hence places it in a different
category from other growth factors which overcome contact inhibition.
Other data obtained from this in vitro model indicate that MC are
stimulated by PDGF as well as IL-i and EGF but are inhibited by IL-2
and IFN-y. This suggests that MC proliferation in vivo may be
controlled by these cytokines and the relevance of these observations to
normal and pathological growth needs to be determined.
Epitopes recognized by anti-neutrophil cytoplasm antibodies. J.A.
Savige, M. Gallichio, I. Mavrova, D.J. Davies, P. Kincaid-Smith,
Department of Nephrology, Royal Melbourne Hospital and St. Vin-
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cent's Hospital, Melbourne, Australia. Anti-neutrophil cytoplasm an-
tibodies are directed against extranuclear components of granulocytes
and monocytes and have been described in a number of small vessel
vasculitides, including Wegener's granulomatosis and microscopic poly-
arteritis. Three different patterns of cytoplasm staining have been
demonstrated by indirect immunofluorescence and we have studied the
epitopes recognised by these antibodies using Western blots. Neutro-
phil cytoplasm extract was prepared as follows. Granulocytes were
collected on successive 6% dextran/O.9% NaCI and Ficoll gradients,
and the red blood cells were lyzed with Tris ammonium chloride pH 7.2.
WBC were subsequently lyzed with Triton X-lO0 in the presence of
protease inhibitors and the neutrophil extract was run in a 6% acryl-
amide gel before transfer to nitrocellulose and blotting. We were able to
identify an antigen of about 125 kD in unreduced gels in a case each of
necrotizing glomerulonephritis and Wegener's granulomatosis. In par-
tially degraded preparations, identically-sized bands were identified
with both sera but with different intensities. The serum from a patient
with atrial myxoma and constitutional features also bound to the
same-sized bands. After trypsin digestion a fragment 25—35 kD, which
has been described elsewhere as the size of the target molecule, was
demonstrated. The nature of the molecule against which these antibod-
ies are directed remains unclear.
Aluminum: A needless risk for dialysis patients? R. Hombrouckx,
A.M. Bogaert, F. Leroy, R. Beelen, J. I'. De Vos, Dialysis Unit, Kliniek
Hogerlucht, Ronse, Belgium. Five years ago we decided to drastically
reduce the p.o. Al(OH)3 intake for controlling serum phosphate levels.
We replaced it by CaCO3 and in a lesser degree by Mg(OH)2; only
exceptionally Al(OH)3 was given as third product. Twenty-five chronic
patients were their own control during 2000 dialysis: the period (I): 1982
+ 1983 was compared with period (H): 1987 + 1988. The results: Period
I versus Period II
Serum level Al: 25/9*g/liter p.o. intake: 5.6/0.7 g/day
P: 5.3/5.0 mg%
Ca: 9.9/9.6 mg% 0.2/3.7 g/day
Vit. D: 79.9/70.7 nmol/liter 0.4/0.3 mg/day
Mg: 2.7/2,7mg% 0.2/1.4 g/day
PTH: 1.9/1.5 pg/mI
AIc. Ph.ase: 170/174 mU/mi
We noted a highly significant decrease in Al blood level (water
treatment being unchanged over all these years). The control of
phosphatemia and parathormone level remained perfect; no side-effects
of Ca and Mg were noted. Conclusion: Al(OH)3 intake is a needless risk
for the patients' health; control of phosphatemia can easily be obtained
by CaCO3, eventually in combination with Mg(OH)2 and rarely also
with a small amount of Al(OH)3. Regular control of calcemia and an
adjustment of the Vit. D intake are necessary. In 3 other patients the
daily dosage of Al(OH)3 was increased from 0.9 to 5.7 g; the Al blood
level also rose from 16 to 43 tJliter.
Monitoring renal bone disease, responses to changes in treatment
strategy. MS. Knapp, J.K. Dawborn, W.F. Heale, P.J. Miach, Renal
Unit, Austin Hospital, Heidelberg, Victoria 3084, Australia. Patients
with renal failure are at risk from renal osteodystrophy and from
aluminium osteodystrophy. In 1986 the emphasis of treatment for
patients attending this unit was changed giving more emphasis to oral
calcium supplement action with withdrawal when possible of calcitriol
and of aluminium binders. The targets included moderate hypercalce-
mia in patients on dialysis, and high normocalcemia in patients before
dialysis, with normal or decreasing serum PTH levels, a "normal"
alkaline phosphatase and a "normal" or decreasing serum aluminium.
Plasma phosphate was to be controlled close to normal range, when
possible, with dietary constraints. The monitoring of multiple variables
created difficulties mostly resolved by computer presentations of se-
quential data graphically. There are merits in presenting data as
transforms, e.g. log or reciptocal, (Mcgiven, Will & Knapp: Br Med J
1982) and of real-time statistical monitoring (Knapp et al: Kidney mt
1983) to make decision making easier. Such techniques display individ-
ual patient responses with increasing Ca supplements, typically a
progressive rise in serum calcium, fall in serum alkaline phosphatese
and an associated fall in PTH. The merits of establishing a personal
normal range of alkaline phosphatese for each patient, and not using a
hospital reference range, is obvious from the graphics. The majority of
patients are considered to be satisfactory on low P04 diets and Ca
supplements alone, the exceptions are hetrogeneous and will be illus-
trated using computer graphics.
A comparison of the vascular and glomerular changes in aortic-ligature
and DOCA-salt hypertension. T.D. Hewitson, H. Kamitsuji, J.A. Whit-
worth, P. Kincaid-Smith, Department of Nephrology, Royal Melbourne
Hospital, Parkville, Australia 3050. Animals and histology from two
previous investigations were used to test the hypothesis that a similar
elevation in blood pressure may result in a different sequence of
pathological changes in different experimental models of hypertension,
DOCA-salt and aortic-ligature hypertension in the rat. To assess
differences in morphological parameters, individual animals in the two
groups were paired for the same level of blood pressure at sacrifice (N
= 12). The median systolic blood pressure of the DOCA-salt group was
188 mm Hg (range 150 to 206) compared with 186 mm Hg (range 155 to
200) in the aortic-ligature group. Vascular damage was significantly less
in the DOCA-salt group (P < 0.01). Glomerular lesions, however, were
more severe in the DOCA-salt group. In rats with aortic-ligature
hypertension significantly fewer glomeruli had fibrinoid and/or cres-
cents than in DOCA-salt rats (P < 0.001). There were fewer glomeruli
with epithelial cell droplets (ECD) and fewer ECD per glomerulus in
aortic-ligature when compared with DOCA-salt hypertension (P <
0.001, P < 0.001, respectively). This study highlights the significance of
factors other than blood pressure per se in producing vessel and
glomerular lesions in experimental hypertension.
Focal and segmental sclerosis in a rabbit uninephrectomy model.
Aggravation by repeated pregnancy. D. Packham, T. Hewitson, J.A.
Whitworth, P. Kincaid-Smith, Department of Nephrology, Royal Mel-
bourne Hospital, Melbourne, Victoria, Australia. Four of 5 uninephrec-
tomized virgin (UNx/V) and 4 of 5 uninephrectomized repeatedly
pregnant (UNx/Preg) rabbits developed focal and segmental hyalinosis
and sclerosis (FSHS) in glomeruli. This differed significantly from 2 of
10 FSHS lesions in non-nephrectomized pregnant (NNIP) and 2 of 10
FSHS in non-nephrectomized virgin (NN/V) rabbits at 15 months (P =
0.0026). Focal sclerosis was increased (median 3.6%) in NN/P com-
pared with NN/V (0.4%). After left nephrectomy median right kidney
weights/kg body weight were significantly greater in nephrectomized
rabbits than right kidney from non-nephrectomized rabbits (3.9 g/kg cf
2.6 g/kg, P < 0.001). Glomerular area of largest 10% glomeruli divided
by kidney weight was less in previously uninephrectomized animals
than in nephrectomized (P < 0.001), indicating glomeruli had hypertro-
phied less than tubules. Mean plasma urea was higher at sacrifice (15
months) in UNx/Preg (11.6 0.4 mmol/liter) than in UNX/V (7.7 0.7
mmol/liter). Mean urine protein rose from 0.35 0.4 g/liter to 0.85 0.9
g/liter) during pregnancy in UNx/Preg (P < 0.001) while NN/P remained
constant (0.38 0.07 g/liter). Mean BP of 10 UNx rabbits increased
from 81 3 mmHg to 92 1 mmHg over 15 months (P = 0.022). This
is the first description of focal and segmental hyalinosis and sclerosis
(FSHS) in rabbits.
Plasma exchange (PE) in progressive IgA nephropathy. K. Nicholls, G.
Becker, C. Wright, P. Kincaid-Smith, Department of Nephrology,
Royal Melbourne Hospital, Victoria 3050, Australia. A 3-month thera-
peutic trial of PE was performed in 13 patients with documented
progressive IgA nephropathy. All patients had crescents on biopsy
(median 34%, range 70 to 80%). Comparison of the rate of deterioration
in renal function (slope 1/Cr vs. time) over the 3-month period before,
during and after PE demonstrated significant improvement during PE (P
< 0.01 ANOVA). In 7 patients serum creatinine clearly decreased
during the PE period, and in these patients the post-PE course was
significantly better than pre-PE (ANOVA P < 0.01). Favorable re-
sponse was correlated with rapidity of deterioration before PE (P <
0.01), and was apparent within 4 weeks in those patients who re-
sponded. There was no overall difference between deterioration rates
before and after PE.
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Pre-PE PE Post-PE
Median slope 1/Cr vs.
time (liter/mmol, day x 100) —1.04 0.l7a —0.75
a p < 0.01
We conclude that PE does stabilize renal function in patients with
rapidly progressive IgA nephropathy, but that sustained benefit after its
cessation was seen only in some patients.
False positives in the neutrophil cytoplasmic antibody tests? R. Silver-
strini, J. Quin, S. Kamath, Department of immunopathology, !CPMR,
Westmead Hospital, Westmead, NSW 2145, Australia. The neutrophil
cytoplasmic antibody test (ANCA) has been confirmed by several
groups as being of value in the diagnosis and follow-up of rapidly
progressive glomerulonephritis (RPGN) due to Wegener's granuloma-
tosis (WG) and microscopic polyarteritis nodosa. To determine if other,
cytoplasmic reactive autoantibodies could give false positives, we
tested sera which were positive for anti-smooth muscle (SMA) antimi-
tochondrial (AMA) anti-ribosomal and anti-thyroid microsomal auto-
antibodies in the immunofluorescent ANCA test using ethanol fixed
granulocytes as substrates. The positive control was from a patient with
WG. Four of 7 sera with AMA, one of five with SMA, one of 4 with
anti-ribosomal and one with thyroid microsomal antibodies showed
weak staining of neutrophil cytoplasm. The pattern was different from
the positive control but could be confused with ANCA at lower titers.
Clinical details including serum creatinine made it unlikely that these
patients had RPGN. To avoid any false positives equivocal ANCA-
positive sera should be screened for these other autoantibodies. Alter-
natively, purified antigen from primary granules of neutrophils should
be used as the source of antigen in ELISA and RIA essays for ANCA.
CAT scan as a possible method for the diagnosis of gouty nephropathy.
I. Fraser, P. Kincaid-Smith, B. Tress, W. Hare, Department of
Nephrology, Department of Radiology, Royal Melbourne Hospital,
Victoria 3050, Australia. The diagnosis of gouty nephropathy is depen-
dent upon the identification of urate crystals in renal biopsy specimens.
Characteristic changes in such patients on renal CAT scanning have not
previously been described. We performed renal CAT scans, without
contrast, on five patients (3 male, 2 female; age range 38 to 54 years)
who had had urate crystals identified on renal biopsy. In four of these
patients (3 male, 1 female) small, high attenuation abnormalities were
identified in the renal parenchyma. These changes may correspond with
urate deposits. Further renal CAT scanning of gouty nephropathy
patients, as well as patients with chronic renal failure from other
causes, such as reflux nephropathy, should help define the diagnostic
usefullness of this non-invasive test.
Mechanism of high altitude proteinuria.* M.H. Winderborn, A.R.
Bradwell, Birmingham Medical Research Expeditionary Society, De-
partment of Paediatric Nephrology, East Birmingham Hospital B9 5ST
and Medical School, Birmingham B15 2TH England, United Kingdom.
The mechanism of the glomerular proteinuria that occurs at altitude is
unknown (Winterborn et al: Postgrad Med J 63:179, 1987). We inves-
tigated the possibility that a loss of cell membrane negative charge
might be responsible by comparing the plasma disappearance of neutral
and negatively charged dextrans, On an expedition to the Karakoram 9
subjects were studied at 2,350 m and 9 at 4,640 to 5,340 m, i.e. before
and after developing symptoms of mild acute mountain sickness which
were treated with acetazolamide, a mixture of C14-labelled carboxy
dextran and H3-labelled neutral dextran, each of 50 to 70,000 mol wt,
was injected intravenously. Saliva, urine and blood samples were
collected beforehand and during the following hour and were subse-
quently analyzed for albumin and count rates. At altitude there was no
significant increase in albuminuria, but an increased plasma disappear-
ance rate of negatively charged dextran suggested a loss of negative
charge from the capillary walls. At altitude the ratio of the plasma
half-lives of neutral to negatively charged dextrans increased from 0.8
0.3 to 1.6 0.7 (P = 0.03). No significant change in the dextran
concentration ratio was seen in saliva or urine at altitude. The results
suggest that there is a loss of negative charge from capillary walls on
ascent to high altitude but the mechanism is unclear.
* Supported by Arthur Thompson Trust and Wellcome Research Trust.
Specific hydraulic conductivity of heparin-like polysaccharides and
albumin solutions—Models of glomerular permeability. 0. Zamparo,
W.D. Comper, Department of Biochemistry, Monash University, Clay-
ton, Victoria 3168, Australia. Water filtration resulting from a net
pressure gradient across the glomerular basement membrane (GBM) is
generally considered to occur through the extracellular matrix consist-
ing mainly of water, simple salts, type IV collagen, glycoproteins and
heparin-like polysaccharides (heparan sulphate). The major resistance
to water flow in the GBM is likely to be derived from heparan sulphate.
Another source of flow resistance acting in series may be from the
stagnant layers of albumin at the GBM-capillary interface. The aim of
this investigation was to measure the hydraulic conductivity of these
materials as a function of macromolecular concentration and compare
these values with the published single nephron ultrafiltration coefficient
(1(1) in the rat of 0.1 nl/(smm Hg). Specific hydraulic conductivities (k)
were measured in phosphate buffered saline pH 7.4 by sedimentation
velocity analysis in the ultracentrifuge. Linear regression analysis of the
concentration dependence of K for albumin (in the concentration range
of27—82 mg ml1) gave K = 1.71 x io—' 1 —1.4 0.02 where 1 is the
volume fraction of the polymer; for commercial heparin (20 to 80 mg
ml; used as a model for glomerular heparan sulphate) gave k 2.4 x
lO c1 —0.95 0.16. Assuming a GBM thickness of 150 nm the Kf
translates to a k value of 4.2 x l0 cm2. This value will be on the low
side as there is no correction for the influence of the internal osmotic
pressure of the GBM (particularly from heparan sulphate) on the net
transcapillary pressure. The conclusions from this analysis are that both
heparan sulphate and albumin containing regions will be critically
important in determining Kf(k = l0-'cm2 is obtained from 57mg m1'
albumin or heparin at 25 mg ml ')together with region thicknesses.
Parenchymal involvement in cases of acute pyelonephritis in patients
with normal IVP. 1. Fraser, J. Whitworth, D. Birch, G. Becker, P.
Kincaid-Smith, B. Tress, W. Hare, M. Lichtenstein, Department of
Nephrology, Department of Radiology, and Department of Nuclear
Medicine, The Royal Melbourne Hospital, Victoria 3050, Australia.
The extent of renal parenchymal involvement in acute pyelonephritis
(PN) and hence posible renal damage, has not been adequately demon-
strated in patients with normal kidneys. Parenchymal involvement, as
depicted by abnormalities in dimercaptosuccinic acid scintography
(DMSA) or CAT scanning was investigated in patients with clinical PN
(bacteriuria, loin pain, fever) in whom the acute IVP was normal, all
studies being performed during the acute illness. Twenty-two patients
(4 male, 18 female) were admitted with PN. Median age was 39 years
(range 17—59). CAT scan was available in 19 patients. In 31.6% this was
abnormal. DMSA was available in 16 patients, and was abnormal in
50%. Thirteen patients had both DMSA and CAT scan. Only 2 patients
had a consistent abnormality in both DMSA and CAT scan. Five
patients had an abnormality in one, but not the other. This study
confirms historical pathological studies, which demonstrated focal
dense inflammatory change in PN. Follow-up DMSA will address the
question as to whether subsequent scars form, since IVP has been
previously shown not to demonstrate scarring in such patients.
Percutaneous renal biopsy as a day patient procedure. B.F. Murphy,
A. Macisaac, Renal Unit, St. Vincent's Hospital, Fitzroy, Victoria
3065, Australia. Renal biopsies are traditionally performed as in-patient
procedures. Complications, however, are usually readily apparent
within hours of the procedure. Chronic bed shortage has prompted us to
evaluate renal biopsy as a day patient procedure in selected patients.
Criteria for inclusion were renal size 9 cm by ultrasound, absence of
significant hypertension and the ability to stay in Melbourne with a
partner during the post-biopsy night. Thirteen biopsies have currently
been performed (4 transplant, 9 native kidney). All biopsies were
performed with a Trucut needle after ultrasound localization. Patients
were observed in the Ultrasound Department for 5 hours and were
required to void before discharge. No early complications occurred and
all patients were able to be discharged. On outpatient review at one
week, no patient reported pain or macroscopic hematuria following
discharge from hospital. We conclude that day patient percutaneous
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renal biopsy in selected patients is safe and may provide a partial
solution to bed shortage in renal units.
Beneficial effects of angiotensin converting enzyme (ACE) inhibition on
models of renal disease in the rat. B. Jackson, L. Franze, P. Jablonski,
B. Howden, C.I. Johnston, The University of Melbourne, Department
of Medicine, Austin Hospital, Heidelberg, and Monash University,
Department of Surgery, Monash Medical Centre, Melbourne Victoria,
Australia. We have studied the effects of an ACE inhibitor, and
conventional hypotensive therapy on renal injury in three dissimilar
models of renal disease in the rat. We have previously demonstrated
ACE inhibitor treatment had a therapeutic advantage of Cl + + inhibitor
treatment in the subtotal nephrectomy and streptozotosin diabetes
models of renal disease in the rat. Nephrotoxic serum nephritis was
induced in rats and 4 weeks later each kidney was transplanted to
syngeneic anephric recipients to create a pair of rats with similar renal
injury. One week later treatment with an ACE inhibitor, triple therapy
(reserpine, hydralazine, and hydrochiorothizide) or no treatment was
instituted. Proteinuria was reduced, glomerular filtration preserved and
mortality improved in the ACE inhibitor group despite similar blood
pressure reduction by triple therapy. Our results suggest that ACE
inhibition has a specific benefit on the progression of renal injury across
a broad range of models of renal injury.
Ureteric stenosis in renal transplantation. P. Y. Scarlett, J.H. Wlo-
darczyk, AD. Hibberd, Hunter Transplant Unit, Royal Newcastle
Hospital, Newcastle and Discipline of Community Medicine, Faculty of
Medicine, University of Newcastle, Newcastle, N.S.W. 2300, Austra-
lia. The aim of this study was to examine the effect of transplant
ureteric stenosis (TUS) on transplant and patient survival. Data were
obtained from a consecutive series of 84 transplants [56 cadaveric (CD),
28 living related (LR)] in 81 patients done at the Royal Newcastle
Hospital between 1980 and 1988. The transplant urinary tract was
monitored by either yearly intravenous urography (IVU; before 1986)
or 6 monthly serial ultrasonic examinations plus baseline IVU (after
1986) together with routine transplant function tests. The diagnosis of
TUS was confirmed by either IVU or percutaneous antegrade pyelog-
raphy. Reconstructive urological surgery consisted of either pyeloure-
terostomy or ureteroneocystostomy or balloon diltation with or without
drainage. Three induction immunosuppressive treatment regimes were
used in this period: 1) azathioprine (Aza), prednisolone (P); 2) prophy-
lactic ATGAM, Aza, P; 3) cyclosporin A (double or quadruple).
Univariate and multivariate analyses were done using BMDP programs
on Vax mini-computer. Comparisons between groups were done by the
generalized Wilcoxon statistic. The incidence of TUS was 7 of 84
(8.3%). The transplant survival in the stenosed group was at 1 year
100%, 5 years 86% and in the non-stenosed group at 1 year 64%, 5 years
49% (P> 0.05). By multivariate analysis the difference between the two
groups was partly accounted for by a greater proportion of LR
transplants in the stenosed group (stenosed: 5 of 7 LR; non-stenosed: 21
of 77 LR) but not by treatment regime nor recipient age. Patient
mortality was I of 7 (stenosed) and 27 of 77 (non-stenosed, P> 0.05).
We conclude that TUS managed with these methods did not compro-
mise transplant nor patient survival.
The mechanism of normal proteinuria. B.!. Shand, R.R. Bailey, K.L.
Lynn, R.A. Robson, Department of Nephrology, Christchurch Hospi-
tal, Christchurch, Australia. Proteinuria occurs in humans with normal
renal function in response to factors such as exercise, stress, pain,
altitude and posture. In terms of accepted theories of glomerular
function the concept of 'normal' proteinuna is an enigma. On the basis
of the pore theory proteinuria of glomerular origin requires a structural
alteration in the porosity of the glomerular filter or a decrease in the
electrostatic charge barriers in the glomerular capillary wall. However,
experimental proof of such changes occurring with physiological pro-
teinuria is lacking. Anatomically defined pores have not been detected
in the glomerular basement membrane. Also the mechanism capable of
modifying the force of the charge barriers in the normal kidney has
never been defined. The presence of a pressure-dependent glomerular
filter than can undergo reversible alterations in permeability (i.e.
thixotropic properties) provides a means of explaining the transient
increase in protein excretion that occur intermittently throughout life. A
study was undertaken on urine specimens from healthy subjects under-
going a number of activities in which it was anticipated that intraglo-
merular pressure would be raised. Urinary protein concentrations and
molecular weight profiles were measured on urines collected before and
after the following activities: 10 mm training session by rhythmic
gymnasts, 30 mm playing a variety of wind instruments and a I mm cold
pressor test. In each situation the results showed an increase in urinary
protein excretion and an increased incidence of high molecular weight
proteinuria. These findings provide indirect evidence for ultrafiltration
being controlled by the physical properties of the glomerular filter and
also highlights the shortcomings of the current understanding of gb-
merular filtration.
Neurological complications following OKT3 therapy. S.D. Roger, R.D.
Allen, D.C. Harris, S. Lawrence, J.H. Stewart, J.R. Chapman, Renal
Unit, Wesimead Hospital, Westmead NSW 2145, Australia. The mono-
clonal antibody OKT3 has been increasingly used in organ transplan-
tation. We report our experience with side effects including 2 major
neurological complications. OKT3 was administered to nine patients on
II occasions from 12/3/88 to 4/12/88. Side effects included pyrexia >39°(N = 7), rigors (3), diarrhea (2), tachycardia (6), hypertension (3),
tremor (3), headache (4), post OKT3 CMV infection (2) and meningitis
(2). A 53-year-old man received OKT3 for kidney allograft rejection on
day 5 post-transplant. He became transiently confused and pyrexiab
(38°C) but recovered by the next morning. Six hours after the after the
second dose he again developed a fever and became severely obtunded
with nuchal rigidity and widespread myoclonic jerking. Lumbar punc-
ture revealed an increased protein content (1040 mg/liter) and cell count
(230 x 106/ml neutrophils and 5 x 106/ml mononuclear cells) but was
sterile on culture. EEG showed diffuse slow wave activity. All immu-
nosuppressive therapy was withdrawn and antibiotics instituted. The
fever settled within 24 hours but his coma and meningoencephalitis took
three weeks to recover. A second patient developed severe irritability,
headache, photophobia, fever and neck stiffness after the second dose
of OKT3. The CSF had a raised neutrophil count (99 x 106/ml) but was
sterile on culture. The symptoms and signs settled over the next 24
hours with no further OKT3. We believe on this evidence that extreme
caution is warranted in patients treated with OKT3 who develop
neurological symptoms and signs suggestive of aseptic meningitis.
Living-unrelated renal transplantation in Australia. J. Kelly, E.
Savdie, Renal Unit, St. Vincent's Hospital, Sydney and the Australian
and New Zealand Dialysis and Transplant Registry. The improved graft
survival obtained with cycbosponn A, with both cadaver and one-
haplotype living-related donors, has lead to a renewal of interest in the
possibility of performing renal allografts from unrelated living donors in
both Europe and North America. To examine whether this trend was
apparent in Australia, we requested data on such grafts from the ANZ
D&T Registry which was provided on an anonymous basis. These data
do show an increase in such grafts in Australia; as of 30.4.88 there had
been ten recorded since 1963, but half of these had occurred since
September 1986. The most frequent donor was a spouse or a completely
unrelated volunteer (4 cases each) with donor age ranging from 39 to 67
years and recipient age from 18 months to 57 years. HLA typing was
mostly lacking in the first five cases, but in the most recent five was
"fair" at both the B (one mismatch in four cases and two in one case)
and the DR (no mismatch in one case and one in four cases) loci.
Overall, the results have been poor, four of the grafts failing within a
day of transplantion and five within nine days, usually from acute
rejection or graft vein thrombosis. When compared with the earlier five,
the most recent five grafts have fared no better—three have been lost
within nine days. The Australian experience thus suggests caution
before undertaking this procedure and reinforces the view that it should
only be performed in exceptional circumstances.
Vitamin 86 deficiency in a hemodialysis patient causing sideroblastic
anemia. B. Nankivell, Department of Nephrology, Royal Newcastle
Hospital, N.S. W. 2300, Australia. A 62-year-old woman with analgesic
nephropathy presented after six months maintenance hemodialysis with
a transfusion-dependent sideroblastic anemia associated with grossly
depressed serum Vitamin B6 and erythrocyte glutamate oxalate trans-
aminase (EGOT) enzyme activity. Pyridoxine replacement improved
her average trough hemoglobin (Hb) from 4.8 g/dl to 6.2 g/dl with
elimination of her transfusion requirement. Sideroblastic anemia, re-
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sponsive to pyridoxine in pharmacological doses, is not characterized
by low serum B6 levels. B6 deficiency associated with siderobtastic
anemia has previously been demonstrated only in experimental ani-
mals. Selective 86 deficiency can cause reversible sideroblastic anemia.
A modified plasma filtration (PF) technique as a treatment for hemo-
chromatosis. R. Hombrouckx, A.M. Bogaert, F. Leroy, L. Larno, J. 1'.
De Vos, G. De Rekeneire, C. De Vlieger, Dialysis Unit, Kliniek
Hogerlucht, 9600 Ronse, Belgium. Idiopathic hemochromatosis is a
genetically determined Mendelian recessive metabolic disorder consist-
ing of iron overload of multiple organs (e.g. liver, skin, pancreas, heart)
by an accelerated iron absorption from the gastro-intestinal tract. The
treatment consists in repeated phlebotomies, However, in some pa-
tients a more selective removal of red blood cells (RBC) is necessary
because of hypotensive episodes, epigastric pains and/of asthenia
during phlebotomy. We now have been successfully treating 2 of the
patients with a modified PF-technique for 7 years and 3 years. This
PF-technique consists in a "single needle" system (combining a double
head pump and a subclavian vein catheter or a cubital vein needle) and
a highly permeable plasma filter. The separated plasma is given back to
the patient, and a part of the concentrated RBC (just after the plasma
filter) is drained by an additional blood pump. In this way the patients
support a removal of 250 ml of concentrated RBC very well (Hct value
of the sequestrated blood being ca 66%—the Hct value of the prefilter
blood being 36%), This procedure lasts about 15 mins., and is repeated
every four to eight weeks. The sessions are tolerated very well. The
indicator of the course of the disease is serum ferritin. Early therapy
can result in a normal life span of the patient. The plasma filters are
reused up to 5 times by a reversed ultrafiltration technique and formalin
sterilization.
